Oklahoma 2024 Regular Session

Oklahoma Senate Bill SB475 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New		Differences
1	1
2	2
3		-
4		-
5		-	An Act
6		-	ENROLLED SENATE
7		-	BILL NO. 475 By: Paxton of the Senate
	3	+	ENGR. H. A. to ENGR. S. B. NO. 475 Page 1 1
	4	+	2
	5	+	3
	6	+	4
	7	+	5
	8	+	6
	9	+	7
	10	+	8
	11	+	9
	12	+	10
	13	+	11
	14	+	12
	15	+	13
	16	+	14
	17	+	15
	18	+	16
	19	+	17
	20	+	18
	21	+	19
	22	+	20
	23	+	21
	24	+	22
	25	+	23
	26	+	24
	27	+
	28	+	ENGROSSED HOUSE AMENDME NT
	29	+	TO
	30	+	ENGROSSED SENATE BILL NO . 475 By: Paxton of the Senate
8	31
9	32		and
10	33
11		-	Echols, McDugle, and Lepak
12		-	of the House
	34	+	Echols of the House
13	35
14	36
15	37
16	38
17	39
18	40		An Act relating to the Uniform Controlled Dangerous
19	41		Substances Act; amending 63 O.S. 2021, Section 2-101,
20		-	as last amended by Section 1 of Enrolled House Bill
21		-	No. 1987 of the 1st Session of the 59 th Oklahoma
22		-	Legislature (63 O.S. Supp. 2022, Section 2-101),
23		-	which relates to definitions; defining certain term;
24		-	amending 63 O.S. 2021, Section 2 -110, which relates
25		-	to attorneys; requiring certain attorneys to assist
26		-	Attorney General for specified purposes; amending 63
27		-	O.S. 2021, Section 2-304, which relates to den ial,
	42	+	as amended by Section 4, Cha pter 265, O.S.L. 2022 ( 63
	43	+	O.S. Supp. 2022, Section 2 -101), which relates to
	44	+	definitions; defining certain term; amending 63 O.S.
	45	+	2021, Section 2-110, which relates to attorneys;
	46	+	requiring certain attorneys to assist Attorney
	47	+	General for specified purp oses; amending 63 O.S.
	48	+	2021, Section 2-304, which relates to den ial,
	49	+	revocation, or suspension of regi stration;
	50	+	authorizing certain action; modifying certain
	51	+	registration suspension and revocation guidelines;
	52	+	removing certain administrative penalty
	53	+	authorization; amending 63 O.S. 2021, Section 2-305,
	54	+	which relates to the order to show cause; removing
	55	+	certain order servicing guidelines; requiring certain
	56	+	servicing guidelines; removing certain suspension
	57	+	guidelines; requiring certain written order
	58	+	guidelines; requiring certain final ord er guidelines;
	59	+	requiring certain administr ative proceedings
	60	+	guidelines; permitting certain delegation authority;
	61	+	prohibiting certain de legation authority; requiring
	62	+	certain proceedings guidelines; creating certain
	63	+	suspension exception; permitting certain authority to
	64	+	administrative hearing officers; permitting certain
	65	+	suspensions; permitting certain assessed penalties ;
	66	+	requiring certain hearing guideline; authorizing
	67	+	certain assessed penalties; prohibiting certain
	68	+	assessed fees; requiring certain seizures; requiring
	69	+	certain sample retention; authorizing certain fines;
	70	+	permitting the Director of the Oklahoma State Bureau
	71	+	of Narcotics and Dangerous Drugs Control to prohibit
	72	+	certain reapplication; requiring certain exemption ;
	73	+	amending 63 O.S. 2021, Section 2 -322, which relates
	74	+	to precursor substances r equiring permit or license;
	75	+
	76	+	ENGR. H. A. to ENGR. S. B. NO. 475 Page 2 1
	77	+	2
	78	+	3
	79	+	4
	80	+	5
	81	+	6
	82	+	7
	83	+	8
	84	+	9
	85	+	10
	86	+	11
	87	+	12
	88	+	13
	89	+	14
	90	+	15
	91	+	16
	92	+	17
	93	+	18
	94	+	19
	95	+	20
	96	+	21
	97	+	22
	98	+	23
	99	+	24
	100	+
	101	+	removing certain statutory reference; amending 63
	102	+	O.S. 2021, Section 2 -325, which relates to denial,
	103	+	revocation, or suspension of registra tion; modifying
	104	+	certain requirement; requiring certain registration
	105	+	guideline; amending 63 O.S. 2021, Section 2 -406,
	106	+	which relates to penalties; adding certain unlawful
	107	+	act; updating statutory reference s; updating
	108	+	statutory language; and declaring an emergency.
	109	+
	110	+
	111	+
	112	+
	113	+
	114	+
	115	+
	116	+
	117	+	AUTHOR: Add the following House Coauthor s: McDugle and Lepak
	118	+
	119	+	AMENDMENT NO. 1. Strike the title, enacting clause, and entire bill
	120	+	and insert:
	121	+
	122	+
	123	+
	124	+
	125	+	"An Act relating to the Uniform Controlled Dangerous
	126	+	Substances Act; amending 63 O.S. 2021, Section 2-101,
	127	+	as amended by Section 4, Chapter 265, O.S.L. 2022 ( 63
	128	+	O.S. Supp. 2022, Section 2 -101), which relates to
	129	+	definitions; defining certain term; amending 63 O.S.
	130	+	2021, Section 2-110, which relates to attorneys;
	131	+	requiring certain attorneys to assist Attorney
	132	+	General for specified purposes; amending 63 O.S.
	133	+	2021, Section 2-304, which relates to den ial,
28	134		revocation, or suspension of regi stration;
29	135		authorizing certain action; modifying registration
30	136		suspension and revocation guidelines; removing
31	137		administrative penalty authorizati on; amending 63
32	138		O.S. 2021, Section 2-305, which relates to the order
33	139		to show cause; removing certain order servicing
34	140		guidelines; requiring certain servicing guidelines;
35	141		removing certain suspen sion guidelines; requiring
36	142		certain written order guidelines; requiring certain
37	143		final order guidelines; requiring certain
38	144		administrative proceedings guidelines ; permitting
39	145		certain delegation authority; pr ohibiting certain
40	146		delegation authority; requiring certain proceedings
41	147		guidelines; creating certain suspension exception;
	148	+
	149	+	ENGR. H. A. to ENGR. S. B. NO. 475 Page 3 1
	150	+	2
	151	+	3
	152	+	4
	153	+	5
	154	+	6
	155	+	7
	156	+	8
	157	+	9
	158	+	10
	159	+	11
	160	+	12
	161	+	13
	162	+	14
	163	+	15
	164	+	16
	165	+	17
	166	+	18
	167	+	19
	168	+	20
	169	+	21
	170	+	22
	171	+	23
	172	+	24
	173	+
42	174		permitting certain authority to administrative
43	175		hearing officers; permitting certain suspensions;
44	176		permitting certain assessed penalties ; requiring
45	177		certain hearing guideline; authorizing cer tain
46	178		assessed penalties; prohibiting certain assessed
47	179		fees; requiring certain seizures; requiring certain
48		-
49		-	ENR. S. B. NO. 475 Page 2
50	180		sample retention; authorizing certain fines;
51	181		permitting the Director of the Oklahoma State Bureau
52	182		of Narcotics and Dangerous Drugs Control to prohibit
53	183		certain reapplication; requiring certain exemption;
54		-	amending 63 O.S. 2021, Section 2-322, as last amended
55		-	by Section 1 of Enrolled Senate Bill No . 668 of the
56		-	1st Session of the 59th Oklahoma Legislature , which
57		-	relates to precursor substances requiring permit or
58		-	license; removing certain statutory reference;
59		-	amending 63 O.S. 2021, Section 2 -325, as last amended
60		-	by Section 3 of Enrolled H ouse Bill No. 2282 of the
61		-	1st Session of the 59th Oklahoma Legislature, which
62		-	relates to denial, revocation, or suspension of
63		-	registration; modifying certain requirement;
64		-	requiring certain registration guideline; amending 63
65		-	O.S. 2021, Section 2 -406, which relates to penalties;
66		-	updating statutory references; and declaring an
67		-	emergency.
68		-
69		-
70		-
71		-
72		-
73		-	SUBJECT: Uniform Controlled Dangerous Substance s Act
	184	+	amending 63 O.S. 2021, Section 2-322, which relates
	185	+	to precursor substances requiring permit or license;
	186	+	removing certain statutory reference; amending 63
	187	+	O.S. 2021, Section 2 -325, which relates to denial,
	188	+	revocation, or suspension of r egistration; modifying
	189	+	certain requirement; requiring certain registration
	190	+	guideline; amending 63 O.S. 2021, Section 2 -406,
	191	+	which relates to penalties; updating statutory
	192	+	references; and declaring an emergency.
	193	+
	194	+
	195	+
	196	+
74	197
75	198		BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
76		-
77	199		SECTION 1. AMENDATORY 63 O.S. 2021, Section 2-101, as
78		-	last amended by Section 1 of Enrolled House Bill No. 1987 of the 1 st
79		-	Session of the 59th Oklahoma Legislature (63 O.S. Supp. 2022,
	200	+	amended by Section 4, Ch apter 265, O.S.L. 2022 (63 O.S. Supp. 2022,
80	201		Section 2-101), is amended to read as foll ows:
81		-
82	202		Section 2-101. As used in the Uniform Controlled Dangerous
83	203		Substances Act:
84		-
85	204		1. “Administer” means the direct application of a controlled
86	205		dangerous substance, whether by injection, inhalation, ingestion or
87	206		any other means, to the body of a patient, animal or research
88	207		subject by:
89	208
90		-
91		-	ENR. S. B. NO. 475 Page 3
	209	+	ENGR. H. A. to ENGR. S. B. NO. 475 Page 4 1
	210	+	2
	211	+	3
	212	+	4
	213	+	5
	214	+	6
	215	+	7
	216	+	8
	217	+	9
	218	+	10
	219	+	11
	220	+	12
	221	+	13
	222	+	14
	223	+	15
	224	+	16
	225	+	17
	226	+	18
	227	+	19
	228	+	20
	229	+	21
	230	+	22
	231	+	23
	232	+	24
	233	+
92	234		a. a practitioner (or, in the presence of the
93	235		practitioner, by the authorized agent of the
94	236		practitioner), or
95		-
96	237		b. the patient or research subject at the direction and
97	238		in the presence of the practitioner;
98		-
99	239		2. “Agent” means a peace officer appointed by and who acts on
100	240		behalf of the Director of the Oklahoma State Bureau of Narcotics and
101	241		Dangerous Drugs Control or an authorized person who acts on behalf
102	242		of or at the direction of a person who manufactures, distributes,
103	243		dispenses, prescribes, administers or uses for scientific purposes
104	244		controlled dangerous substances but does not include a common or
105	245		contract carrier, public warehouser or employee thereof, or a person
106	246		required to register under the Uniform Controlled Dangerous
107	247		Substances Act;
108		-
109	248		3. “Board” means the Advisory Board to the Director of the
110	249		Oklahoma State Bureau of Narcotics and Dangerous Drugs Control;
111		-
112	250		4. “Bureau” means the Oklahoma State Bureau of Narcotics and
113	251		Dangerous Drugs Control;
114		-
115	252		5. “Coca leaves” includes cocaine and any compound,
116	253		manufacture, salt, derivative, mixture or preparation of coca
117	254		leaves, except derivatives of coca leaves which do not contain
118	255		cocaine or ecgonine;
119		-
120	256		6. “Commissioner” or “Director” means the Director of the
121	257		Oklahoma State Bureau of Narcotics and Dangerous Drugs Control;
	258	+
	259	+	ENGR. H. A. to ENGR. S. B. NO. 475 Page 5 1
	260	+	2
	261	+	3
	262	+	4
	263	+	5
	264	+	6
	265	+	7
	266	+	8
	267	+	9
	268	+	10
	269	+	11
	270	+	12
	271	+	13
	272	+	14
	273	+	15
	274	+	16
	275	+	17
	276	+	18
	277	+	19
	278	+	20
	279	+	21
	280	+	22
	281	+	23
	282	+	24
122	283
123	284		7. “Control” means to add, remove or change the placement of a
124	285		drug, substance or immediate precursor under the Uniform Controlled
125	286		Dangerous Substances Act;
126		-
127	287		8. “Controlled dangerous substance” means a drug, substance or
128	288		immediate precursor in Schedules I through V of the Uniform
129	289		Controlled Dangerous Substances Act or any drug, substance or
130	290		immediate precursor listed either temporarily or permanently as a
131	291		federally controlled substance. Any conflict between state and
132	292		federal law with regard to the particular schedule in which a
133	293		substance is listed shall be resolved in favor of state law;
134		-
135		-	ENR. S. B. NO. 475 Page 4
136		-
137	294		9. “Counterfeit substance” means a controlled substance which,
138	295		or the container or labeling of which without authorization, bears
139	296		the trademark, trade name or other identifying marks, imprint,
140	297		number or device or any likeness thereof of a manufacturer,
141	298		distributor or dispenser other than the person who in fact
142	299		manufactured, distributed or dispensed the substance;
143		-
144	300		10. “Deliver” or “delivery” means the actual, constructive or
145	301		attempted transfer from one person to another of a controlled
146	302		dangerous substance or drug paraphernalia, whether or not there is
147	303		an agency relationship;
148		-
149	304		11. “Dispense” means to deliver a controlled dangerous
150	305		substance to an ultimate user or human research subject by or
151	306		pursuant to the lawful order of a practitioner, including the
152	307		prescribing, administering, packaging, labeling or compounding
	308	+
	309	+	ENGR. H. A. to ENGR. S. B. NO. 475 Page 6 1
	310	+	2
	311	+	3
	312	+	4
	313	+	5
	314	+	6
	315	+	7
	316	+	8
	317	+	9
	318	+	10
	319	+	11
	320	+	12
	321	+	13
	322	+	14
	323	+	15
	324	+	16
	325	+	17
	326	+	18
	327	+	19
	328	+	20
	329	+	21
	330	+	22
	331	+	23
	332	+	24
	333	+
153	334		necessary to prepare the substance for such distribution.
154	335		“Dispenser” is a practitioner who delivers a controlled dangerous
155	336		substance to an ultimate user or human research subject;
156		-
157	337		12. “Distribute” means to deliver other than by administering
158	338		or dispensing a controlled dangerous substance;
159		-
160	339		13. “Distributor” means a commercial entity engaged in the
161	340		distribution or reverse distribution of narcotics and dangerous
162	341		drugs and who complies with all regulations promulgated by the
163	342		federal Drug Enforcement Administration and the Oklahoma State
164	343		Bureau of Narcotics and Dangerous Drugs Control;
165		-
166	344		14. “Drug” means articles:
167		-
168	345		a. recognized in the official United States Pharmacopeia,
169	346		official Homeopathic Pharmacopoeia of the United
170	347		States, or official National Formulary, or any
171	348		supplement to any of them,
172		-
173	349		b. intended for use in the diagnosis, cure, mitigation,
174	350		treatment or prevention of disease in man or other
175	351		animals,
176		-
177		-
178		-	ENR. S. B. NO. 475 Page 5
179	352		c. other than food, intended to affect the structure or
180	353		any function of the body of man or other animals, and
181		-
182	354		d. intended for use as a component of any article
183	355		specified in this paragraph;
184		-
185	356		provided, however, the term “drug” drug does not include devices or
186	357		their components, parts or accessories;
	358	+
	359	+	ENGR. H. A. to ENGR. S. B. NO. 475 Page 7 1
	360	+	2
	361	+	3
	362	+	4
	363	+	5
	364	+	6
	365	+	7
	366	+	8
	367	+	9
	368	+	10
	369	+	11
	370	+	12
	371	+	13
	372	+	14
	373	+	15
	374	+	16
	375	+	17
	376	+	18
	377	+	19
	378	+	20
	379	+	21
	380	+	22
	381	+	23
	382	+	24
187	383
188	384		15. “Drug-dependent person” means a person who is using a
189	385		controlled dangerous substance and who is in a state of psychic or
190	386		physical dependence, or both, arising from administration of that
191	387		controlled dangerous substance on a continuous basis. Drug
192	388		dependence is characterized by behavioral and other responses which
193	389		include a strong compulsion to take the substance on a continuous
194	390		basis in order to experience its psychic effects, or to avoid the
195	391		discomfort of its absence;
196		-
197	392		16. “Home care agency” means any sole proprietorship,
198	393		partnership, association, corporation, or other organization which
199	394		administers, offers, or provides home care services, for a fee or
200	395		pursuant to a contract for such services, to clients in their place
201	396		of residence;
202		-
203	397		17. “Home care services” means skilled or personal care
204	398		services provided to clients in their place of residence for a fee;
205		-
206	399		18. “Hospice” means a centrally administered, nonprofit or for-
207	400		profit, medically directed, nurse-coordinated program which provides
208	401		a continuum of home and inpatient care for the terminally ill
209	402		patient and the patient’s family. Such term shall also include a
210	403		centrally administered, nonprofit or for-profit, medically directed,
211	404		nurse-coordinated program if such program is licensed pursuant to
212	405		the provisions of the Uniform Controlled Dangerous Substances Act.
213	406		A hospice program offers palliative and supportive care to meet the
214	407		special needs arising out of the physical, emotional and spiritual
	408	+
	409	+	ENGR. H. A. to ENGR. S. B. NO. 475 Page 8 1
	410	+	2
	411	+	3
	412	+	4
	413	+	5
	414	+	6
	415	+	7
	416	+	8
	417	+	9
	418	+	10
	419	+	11
	420	+	12
	421	+	13
	422	+	14
	423	+	15
	424	+	16
	425	+	17
	426	+	18
	427	+	19
	428	+	20
	429	+	21
	430	+	22
	431	+	23
	432	+	24
	433	+
215	434		stresses which are experienced during the final stages of illness
216	435		and during dying and bereavement. This care is available twenty-
217	436		four (24) hours a day, seven (7) days a week, and is provided on the
218	437		basis of need, regardless of ability to pay. “Class A” Hospice
219	438		refers to Medicare-certified hospices. “Class B” refers to all
220	439		other providers of hospice services;
221		-
222		-	ENR. S. B. NO. 475 Page 6
223		-
224	440		19. “Imitation controlled substance” means a substance that is
225	441		not a controlled dangerous substance, which by dosage unit
226	442		appearance, color, shape, size, markings or by representations made,
227	443		would lead a reasonable person to believe that the substance is a
228	444		controlled dangerous substance. In the event the appearance of the
229	445		dosage unit is not reasonably sufficient to establish that the
230	446		substance is an “imitation controlled substance” imitation
231	447		controlled substance, the court or authority concerned should
232	448		consider, in addition to all oth er factors, the following factors as
233	449		related to “representations made” in determining wheth er the
234	450		substance is an “imitation controlled substance” imitation
235	451		controlled substance:
236		-
237	452		a. statements made by an owner or by any other person in
238	453		control of the substance concerning the nature of the
239	454		substance, or its use or effect,
240		-
241	455		b. statements made to the recipient that the substance
242	456		may be resold for inordinate profit,
243	457
	458	+	ENGR. H. A. to ENGR. S. B. NO. 475 Page 9 1
	459	+	2
	460	+	3
	461	+	4
	462	+	5
	463	+	6
	464	+	7
	465	+	8
	466	+	9
	467	+	10
	468	+	11
	469	+	12
	470	+	13
	471	+	14
	472	+	15
	473	+	16
	474	+	17
	475	+	18
	476	+	19
	477	+	20
	478	+	21
	479	+	22
	480	+	23
	481	+	24
	482	+
244	483		c. whether the substance is packaged in a manner normally
245	484		used for illicit controlled substances,
246		-
247	485		d. evasive tactics or actions utilized by the owner or
248	486		person in control of the substance to avoid detection
249	487		by law enforcement authorities,
250		-
251	488		e. prior convictions, if any, of an owner, or any other
252	489		person in control of the object, under state or
253	490		federal law related to controlled substances or fraud,
254	491		and
255		-
256	492		f. the proximity of the substances to controlled
257	493		dangerous substances;
258		-
259	494		20. “Immediate precursor” means a substance which the Director
260	495		has found to be and by regulation designates as being the principal
261	496		compound commonly used or produced primarily for use, and which is
262	497		an immediate chemical intermediary used, or likely to be used, in
263	498		the manufacture of a controlled dangerous substance, the control of
264	499		which is necessary to prevent, curtail or limit such manufacture;
265		-
266		-	ENR. S. B. NO. 475 Page 7
267		-
268	500		21. “Laboratory” means a laboratory approved by the Director as
269	501		proper to be entrusted with the custody of controlled dangerous
270	502		substances and the use of controlled dangerous substances for
271	503		scientific and medical purposes and for purposes of instruction;
272		-
273	504		22. “Manufacture” means the production, preparation,
274	505		propagation, compounding or processing of a controlled dangerous
275	506		substance, either directly or indirectly by extraction from
	507	+
	508	+	ENGR. H. A. to ENGR. S. B. NO. 475 Page 10 1
	509	+	2
	510	+	3
	511	+	4
	512	+	5
	513	+	6
	514	+	7
	515	+	8
	516	+	9
	517	+	10
	518	+	11
	519	+	12
	520	+	13
	521	+	14
	522	+	15
	523	+	16
	524	+	17
	525	+	18
	526	+	19
	527	+	20
	528	+	21
	529	+	22
	530	+	23
	531	+	24
	532	+
276	533		substances of natural or synthetic origin, or independently by means
277	534		of chemical synthesis or by a combination of extraction and chemical
278	535		synthesis. “Manufacturer” includes any person who packages,
279	536		repackages or labels any container of any controlled dangerous
280	537		substance, except practitioners who dispense or compound
281	538		prescription orders for delivery to the ultimate consumer;
282		-
283	539		23. “Marijuana” means all parts of the plant Cannabis sativa
284	540		L., whether growing or not; the seeds thereof; the resin extracted
285	541		from any part of such plant; and every compound, manufacture, salt,
286	542		derivative, mixture or preparation of such plant, its seeds or
287	543		resin, but shall not include:
288		-
289	544		a. the mature stalks of such plant or fiber produced from
290	545		such stalks,
291		-
292	546		b. oil or cake made from the seeds of such plant,
293	547		including cannabidiol derived from the seeds of the
294	548		marijuana plant,
295		-
296	549		c. any other compound, manufacture, salt, derivative,
297	550		mixture or preparation of such mature stalks (except
298	551		the resin extracted therefrom), including cannabidiol
299	552		derived from mature stalks, fiber, oil or cake,
300		-
301	553		d. the sterilized seed of such plant which is incapable
302	554		of germination,
303		-
304	555		e. for any person participating in a clinical trial to
305	556		administer cannabidiol for the treatment of severe
	557	+
	558	+	ENGR. H. A. to ENGR. S. B. NO. 475 Page 11 1
	559	+	2
	560	+	3
	561	+	4
	562	+	5
	563	+	6
	564	+	7
	565	+	8
	566	+	9
	567	+	10
	568	+	11
	569	+	12
	570	+	13
	571	+	14
	572	+	15
	573	+	16
	574	+	17
	575	+	18
	576	+	19
	577	+	20
	578	+	21
	579	+	22
	580	+	23
	581	+	24
	582	+
306	583		forms of epilepsy pursuant to Section 2-802 of this
307	584		title, a drug or substance approved by the federal
308		-
309		-	ENR. S. B. NO. 475 Page 8
310	585		Food and Drug Administration for use by those
311	586		participants,
312		-
313	587		f. for any person or the parents, legal guardians or
314	588		caretakers of the person who have received a written
315	589		certification from a physician licensed in this state
316	590		that the person has been diagnosed by a physician as
317	591		having Lennox-Gastaut syndrome, Dravet syndrome, also
318	592		known as severe myoclonic epilepsy of infancy, or any
319	593		other severe form of epilepsy that is not adequately
320	594		treated by traditional medical therapies, spasticity
321	595		due to multiple sclerosis or due to paraplegia,
322	596		intractable nausea and vomiting, appetite stimulation
323	597		with chronic wasting diseases, the substance
324	598		cannabidiol, a nonpsychoactive cannabinoid, found in
325	599		the plant Cannabis sativa L. or any other preparation
326	600		thereof, that has a tetrahydrocannabinol concentration
327	601		of not more than three-tenths of one percent (0.3%)
328	602		and that is delivered to the patient in the form of a
329	603		liquid,
330		-
331	604		g. any federal Food-and-Drug-Administration-approved drug
332	605		or substance, or
	606	+
	607	+	ENGR. H. A. to ENGR. S. B. NO. 475 Page 12 1
	608	+	2
	609	+	3
	610	+	4
	611	+	5
	612	+	6
	613	+	7
	614	+	8
	615	+	9
	616	+	10
	617	+	11
	618	+	12
	619	+	13
	620	+	14
	621	+	15
	622	+	16
	623	+	17
	624	+	18
	625	+	19
	626	+	20
	627	+	21
	628	+	22
	629	+	23
	630	+	24
333	631
334	632		h. industrial hemp, from the plant Cannabis sativa L. and
335	633		any part of such plant, whether growing or not, with a
336	634		delta-9 tetrahydrocannabinol concentration of not more
337	635		than three-tenths of one percent (0.3%) on a dry-
338	636		weight basis which shall only be grown pursuant to the
339	637		Oklahoma Industrial Hemp Program and may be shipped
340	638		intrastate and interstate;
341		-
342	639		24. “Medical purpose” means an intention to utilize a
343	640		controlled dangerous substance for physical or mental treatment, for
344	641		diagnosis, or for the prevention of a disease condition not in
345	642		violation of any state or federal law and not for the purpose of
346	643		satisfying physiological or psychological dependence or other abuse;
347		-
348	644		25. “Mid-level practitioner” means an Advanced Practice
349	645		Registered Nurse as defined and within parameters specified in
350	646		Section 567.3a of Title 59 of the Oklahoma Statutes, or a certified
351	647		animal euthanasia technician as defined in Section 698.2 of Title 59
352		-
353		-	ENR. S. B. NO. 475 Page 9
354	648		of the Oklahoma Statutes, or an animal control officer registered by
355	649		the Oklahoma State Bureau of Narcotics and Dangerous Drugs Control
356	650		under subsection B of Section 2-301 of this title within the
357	651		parameters of such officer’s duties under Sections 501 through 508
358	652		of Title 4 of the Oklahoma Statutes;
359		-
360	653		26. “Narcotic drug” means any of the following, whether
361	654		produced directly or indirectly by extraction from substances of
	655	+
	656	+	ENGR. H. A. to ENGR. S. B. NO. 475 Page 13 1
	657	+	2
	658	+	3
	659	+	4
	660	+	5
	661	+	6
	662	+	7
	663	+	8
	664	+	9
	665	+	10
	666	+	11
	667	+	12
	668	+	13
	669	+	14
	670	+	15
	671	+	16
	672	+	17
	673	+	18
	674	+	19
	675	+	20
	676	+	21
	677	+	22
	678	+	23
	679	+	24
	680	+
362	681		vegetable origin, or independently b y means of chemical synthesis,
363	682		or by a combination of extraction and chemical synthesis:
364		-
365	683		a. opium, coca leaves and opiates,
366		-
367	684		b. a compound, manufacture, salt, derivative or
368	685		preparation of opium, coca leaves or opiates,
369		-
370	686		c. cocaine, its salts, optical and geo metric isomers, and
371	687		salts of isomers,
372		-
373	688		d. ecgonine, its derivatives, their salts, isomers and
374	689		salts of isomers, and
375		-
376	690		e. a substance, and any compound, manufacture, salt,
377	691		derivative or preparation thereof, which is chemically
378	692		identical with any of the substan ces referred to in
379	693		subparagraphs a through d of this paragraph, except
380	694		that the words “narcotic drug” narcotic drug as used
381	695		in Section 2-101 et seq. of this title shall not
382	696		include decocainized coca leaves or extracts of coca
383	697		leaves, which extracts do not contain cocain e or
384	698		ecgonine;
385		-
386	699		27. “Opiate” or “opioid” means any Schedule II, III, IV or V
387	700		substance having an addiction-forming or addiction-sustaining
388	701		liability similar to morphine or being capable of conversion into a
389	702		drug having such addiction-forming or addiction -sustaining
390	703		liability. The terms do not include, unless specifically designated
391	704		as controlled under the Uniform Controlled Dangerous Substances Act,
	705	+
	706	+	ENGR. H. A. to ENGR. S. B. NO. 475 Page 14 1
	707	+	2
	708	+	3
	709	+	4
	710	+	5
	711	+	6
	712	+	7
	713	+	8
	714	+	9
	715	+	10
	716	+	11
	717	+	12
	718	+	13
	719	+	14
	720	+	15
	721	+	16
	722	+	17
	723	+	18
	724	+	19
	725	+	20
	726	+	21
	727	+	22
	728	+	23
	729	+	24
	730	+
392	731		the dextrorotatory isomer of 3-methoxy-n-methyl-morphinan and its
393	732		salts (dextromethorphan). The terms do include the racemic and
394	733		levorotatory forms;
395		-
396		-
397		-	ENR. S. B. NO. 475 Page 10
398	734		28. “Opium poppy” means the plant of the species Papaver
399	735		somniferum L., except the seeds thereof;
400		-
401	736		29. “Peace officer” means a police officer, sheriff, deputy
402	737		sheriff, district attorney’s investigator, investigato r from the
403	738		Office of the Attorney General, or any other person elected or
404	739		appointed by law to enforce any of the criminal laws of this state
405	740		or of the United States;
406		-
407	741		30. “Person” means an individual, corporation, government or
408	742		governmental subdivision or agency, business trust, estate, trust,
409	743		partnership or association, or any other legal entity;
410		-
411	744		31. “Poppy straw” means all parts, except the seeds, of the
412	745		opium poppy, after mowing;
413		-
414	746		32. “Practitioner” means:
415		-
416	747		a. (1) a medical doctor or osteopathic physicia n,
417		-
418	748		(2) a dentist,
419		-
420	749		(3) a podiatrist,
421		-
422	750		(4) an optometrist,
423		-
424	751		(5) a veterinarian,
425		-
426	752		(6) a physician assistant or Advanced Practice
427	753		Registered Nurse under the supervision of a
428	754		licensed medical doctor or osteopathic physician,
429	755
	756	+	ENGR. H. A. to ENGR. S. B. NO. 475 Page 15 1
	757	+	2
	758	+	3
	759	+	4
	760	+	5
	761	+	6
	762	+	7
	763	+	8
	764	+	9
	765	+	10
	766	+	11
	767	+	12
	768	+	13
	769	+	14
	770	+	15
	771	+	16
	772	+	17
	773	+	18
	774	+	19
	775	+	20
	776	+	21
	777	+	22
	778	+	23
	779	+	24
	780	+
430	781		(7) a scientific investigator, or
431		-
432	782		(8) any other person,
433		-
434	783		licensed, registered or otherwise permitted to
435	784		prescribe, distribute, dispense, conduct research with
436	785		respect to, use for scientific purposes or administer
437	786		a controlled dangerous substance in the course of
438	787		professional practice or research in this state, or
439		-
440		-
441		-	ENR. S. B. NO. 475 Page 11
442	788		b. a pharmacy, hospital, laboratory or other institution
443	789		licensed, registered or otherwise permitted to
444	790		distribute, dispense, conduct research with respect
445	791		to, use for scientific purposes or administer a
446	792		controlled dangerous substance in the course of
447	793		professional practice or research in this state;
448		-
449	794		33. “Production” includes the manufacture, planting,
450	795		cultivation, growing or harvesting of a controlled dangerous
451	796		substance;
452		-
453	797		34. “State” means the State of Oklahoma or any other state of
454	798		the United States;
455		-
456	799		35. “Ultimate user” means a person who lawfully possesses a
457	800		controlled dangerous substance for the person’s own use or for the
458	801		use of a member of the person’s household or for administration to
459	802		an animal owned by the person or by a member of the person’s
460	803		household;
	804	+
	805	+	ENGR. H. A. to ENGR. S. B. NO. 475 Page 16 1
	806	+	2
	807	+	3
	808	+	4
	809	+	5
	810	+	6
	811	+	7
	812	+	8
	813	+	9
	814	+	10
	815	+	11
	816	+	12
	817	+	13
	818	+	14
	819	+	15
	820	+	16
	821	+	17
	822	+	18
	823	+	19
	824	+	20
	825	+	21
	826	+	22
	827	+	23
	828	+	24
461	829
462	830		36. “Drug paraphernalia” means all equipment, products and
463	831		materials of any kind which are used, intended for use, or fashioned
464	832		specifically for use in planting, propagating, cultivating, growing,
465	833		harvesting, manufacturing, comp ounding, converting, producing,
466	834		processing, preparing, testing, analyzing, packaging, repackaging,
467	835		storing, containing, concealing, injecting, ingesting, inhaling or
468	836		otherwise introducing into the human body, a controlled dangerous
469	837		substance in violation o f the Uniform Controlled Dangerous
470	838		Substances Act including, but not limited to:
471		-
472	839		a. kits used, intended for use, or fashioned specifically
473	840		for use in planting, propagating, cultivating, growing
474	841		or harvesting of any species of plant which is a
475	842		controlled dangerous substance or from which a
476	843		controlled dangerous substance can be derived,
477		-
478	844		b. kits used, intended for use, or fashioned specifically
479	845		for use in manufacturing, compounding, converting,
480	846		producing, processing or preparing controlled
481	847		dangerous substances ,
482		-
483		-
484		-	ENR. S. B. NO. 475 Page 12
485	848		c. isomerization devices used, intended for use, or
486	849		fashioned specifically for use in increasing the
487	850		potency of any species of plant which is a controlled
488	851		dangerous substance,
489		-
490	852		d. testing equipment used, intended for use, or fashioned
491	853		specifically for use in identifying, or in analyzing
	854	+
	855	+	ENGR. H. A. to ENGR. S. B. NO. 475 Page 17 1
	856	+	2
	857	+	3
	858	+	4
	859	+	5
	860	+	6
	861	+	7
	862	+	8
	863	+	9
	864	+	10
	865	+	11
	866	+	12
	867	+	13
	868	+	14
	869	+	15
	870	+	16
	871	+	17
	872	+	18
	873	+	19
	874	+	20
	875	+	21
	876	+	22
	877	+	23
	878	+	24
	879	+
492	880		the strength, effectiveness or purity of controlled
493	881		dangerous substances,
494		-
495	882		e. scales and balances used, intended for use, or
496	883		fashioned specifically for use in weighing or
497	884		measuring controlled dangerous substances,
498		-
499	885		f. diluents and adulterants, such as quinine
500	886		hydrochloride, mannitol, mannite, dextrose and
501	887		lactose, used, intended for use, or fashioned
502	888		specifically for use in cutting controlled dangerous
503	889		substances,
504		-
505	890		g. separation gins and sifters used, intended for use, or
506	891		fashioned specifically for use in removing twigs and
507	892		seeds from, or in otherwise cleaning or refining,
508	893		marijuana,
509		-
510	894		h. blenders, bowls, containers, spoons and mixing devices
511	895		used, intended for use, or fashioned specifically for
512	896		use in compounding controlled dange rous substances,
513		-
514	897		i. capsules, balloons, envelopes and other containers
515	898		used, intended for use, or fashioned specifically for
516	899		use in packaging small quantities of controlled
517	900		dangerous substances,
518		-
519	901		j. containers and other objects used, intended for use,
520	902		or fashioned specifically for use in parenterally
	903	+
	904	+	ENGR. H. A. to ENGR. S. B. NO. 475 Page 18 1
	905	+	2
	906	+	3
	907	+	4
	908	+	5
	909	+	6
	910	+	7
	911	+	8
	912	+	9
	913	+	10
	914	+	11
	915	+	12
	916	+	13
	917	+	14
	918	+	15
	919	+	16
	920	+	17
	921	+	18
	922	+	19
	923	+	20
	924	+	21
	925	+	22
	926	+	23
	927	+	24
	928	+
521	929		injecting controlled dangerous substances into the
522	930		human body,
523		-
524	931		k. hypodermic syringes, needles and other objects used,
525	932		intended for use, or fashioned specifically for use in
526		-
527		-	ENR. S. B. NO. 475 Page 13
528	933		parenterally injecting controlled dan gerous substances
529	934		into the human body,
530		-
531	935		l. objects used, intended for use, or fashioned
532	936		specifically for use in ingesting, inhaling or
533	937		otherwise introducing marijuana, cocaine, hashish or
534	938		hashish oil into the human body, such as:
535		-
536	939		(1) metal, wooden, acrylic, glass, stone, plastic or
537	940		ceramic pipes with or without screens, permanent
538	941		screens, hashish heads or punctured metal bowls,
539		-
540	942		(2) water pipes,
541		-
542	943		(3) carburetion tubes and devices,
543		-
544	944		(4) smoking and carburetion masks,
545		-
546	945		(5) roach clips, meaning objects used to hold burning
547	946		material, such as a marijuana cigarette, that has
548	947		become too small or too short to be held in the
549	948		hand,
550		-
551	949		(6) miniature cocaine spoons and cocaine vials,
552		-
553	950		(7) chamber pipes,
554		-
555	951		(8) carburetor pipes,
556		-
557	952		(9) electric pipes,
558	953
	954	+	ENGR. H. A. to ENGR. S. B. NO. 475 Page 19 1
	955	+	2
	956	+	3
	957	+	4
	958	+	5
	959	+	6
	960	+	7
	961	+	8
	962	+	9
	963	+	10
	964	+	11
	965	+	12
	966	+	13
	967	+	14
	968	+	15
	969	+	16
	970	+	17
	971	+	18
	972	+	19
	973	+	20
	974	+	21
	975	+	22
	976	+	23
	977	+	24
	978	+
559	979		(10) air-driven pipes,
560		-
561	980		(11) chillums,
562		-
563	981		(12) bongs, or
564		-
565	982		(13) ice pipes or chillers,
566		-
567	983		m. all hidden or novelty pipes, and
568		-
569		-
570		-	ENR. S. B. NO. 475 Page 14
571	984		n. any pipe that has a tobacco bowl or chamber of less
572	985		than one-half (1/2) inch in diameter in which there is
573	986		any detectable residue of any controlled dangerous
574	987		substance as defined in this section or any other
575	988		substances not legal for possession or use;
576		-
577	989		provided, however, the term “drug paraphernalia” drug paraphernalia
578	990		shall not include separation gins intended for use in preparing tea
579	991		or spice, clamps used for constructing electrical equ ipment, water
580	992		pipes designed for ornamentation in which no detectable amount of an
581	993		illegal substance is found or pipes designed and used solely for
582	994		smoking tobacco, traditional pipes of an American Indian tribal
583		-	religious ceremony, antique pipes that ar e thirty (30) years of age
584		-	or older, or drug testing st rips possessed by a person for purposes
585		-	of determining the presence of fentanyl or a fentanyl-related
586		-	compound;
587		-
	995	+	religious ceremony, or antique pipes that ar e thirty (30) years of
	996	+	age or older;
588	997		37. a. “Synthetic controlled substance” means a substance:
589		-
590	998		(1) the chemical structure of which is substantially
591	999		similar to the chemical structure of a controlled
592	1000		dangerous substance in Schedule I or II,
593		-
594	1001		(2) which has a stimulant, depressant, or
595	1002		hallucinogenic effect on the cent ral nervous
	1003	+
	1004	+	ENGR. H. A. to ENGR. S. B. NO. 475 Page 20 1
	1005	+	2
	1006	+	3
	1007	+	4
	1008	+	5
	1009	+	6
	1010	+	7
	1011	+	8
	1012	+	9
	1013	+	10
	1014	+	11
	1015	+	12
	1016	+	13
	1017	+	14
	1018	+	15
	1019	+	16
	1020	+	17
	1021	+	18
	1022	+	19
	1023	+	20
	1024	+	21
	1025	+	22
	1026	+	23
	1027	+	24
	1028	+
596	1029		system that is substantially similar to or
597	1030		greater than the stimulant, depressant or
598	1031		hallucinogenic effect on the central nervous
599	1032		system of a controlled dangerous substance in
600	1033		Schedule I or II, or
601		-
602	1034		(3) with respect to a particular person, which such
603	1035		person represents or intends to have a stimulant,
604	1036		depressant, or hallucinogenic effect on the
605	1037		central nervous system that is substantially
606	1038		similar to or greater than the stimulant,
607	1039		depressant, or hallucinogenic effect on the
608	1040		central nervous system of a controlled dangerous
609	1041		substance in Schedule I or II.
610		-
611	1042		b. The designation of gamma butyrolactone or any other
612	1043		chemical as a precursor, pursuant to Section 2-322 of
613		-
614		-	ENR. S. B. NO. 475 Page 15
615	1044		this title, does not preclude a finding pursuant to
616	1045		subparagraph a of this paragraph that the chemical is
617	1046		a synthetic controlled substance.
618		-
619	1047		c. “Synthetic controlled substance” does not include:
620		-
621	1048		(1) a controlled dangerous substance,
622		-
623	1049		(2) any substance for which there is an approved new
624	1050		drug application,
625		-
626	1051		(3) with respect to a particular person any
627	1052		substance, if an exemption is in effect for
	1053	+
	1054	+	ENGR. H. A. to ENGR. S. B. NO. 475 Page 21 1
	1055	+	2
	1056	+	3
	1057	+	4
	1058	+	5
	1059	+	6
	1060	+	7
	1061	+	8
	1062	+	9
	1063	+	10
	1064	+	11
	1065	+	12
	1066	+	13
	1067	+	14
	1068	+	15
	1069	+	16
	1070	+	17
	1071	+	18
	1072	+	19
	1073	+	20
	1074	+	21
	1075	+	22
	1076	+	23
	1077	+	24
	1078	+
628	1079		investigational use, for that person under the
629	1080		provisions of Section 505 of the Federal Food,
630	1081		Drug and Cosmetic Act, Title 21 of the United
631	1082		States Code, Section 355, to the extent conduct
632	1083		with respect to such subst ance is pursuant to
633	1084		such exemption, or
634		-
635	1085		(4) any substance to the extent not intended for
636	1086		human consumption before such an exemption takes
637	1087		effect with respect to that substance.
638		-
639	1088		d. Prima facie evidence that a substance containing
640	1089		salvia divinorum has been en hanced, concentrated or
641	1090		chemically or physically altered shall give rise to a
642	1091		rebuttable presumption that the substance is a
643	1092		synthetic controlled substance;
644		-
645	1093		38. “Tetrahydrocannabinols” means all substances that have been
646	1094		chemically synthesized to emulate the tetrahydrocannabinols of
647	1095		marijuana, specifically including any tetrahydrocannabinols derived
648	1096		from industrial hemp;
649		-
650	1097		39. “Isomer” means the optical isomer, except as used in
651	1098		subsections C and F of Section 2-204 of this title and paragraph 4
652	1099		of subsection A of Section 2-206 of this title. As used in
653	1100		subsections C and F of Section 2-204 of this title, “isomer” isomer
654	1101		means the optical, positional or geometric isomer. As used in
	1102	+
	1103	+	ENGR. H. A. to ENGR. S. B. NO. 475 Page 22 1
	1104	+	2
	1105	+	3
	1106	+	4
	1107	+	5
	1108	+	6
	1109	+	7
	1110	+	8
	1111	+	9
	1112	+	10
	1113	+	11
	1114	+	12
	1115	+	13
	1116	+	14
	1117	+	15
	1118	+	16
	1119	+	17
	1120	+	18
	1121	+	19
	1122	+	20
	1123	+	21
	1124	+	22
	1125	+	23
	1126	+	24
	1127	+
655	1128		paragraph 4 of subsection A of Section 2-206 of this title, the term
656	1129		“isomer” isomer means the optical or geometric isomer;
657		-
658		-	ENR. S. B. NO. 475 Page 16
659		-
660	1130		40. “Hazardous materials” means materials, whether solid,
661	1131		liquid or gas, which are toxic to human, animal, aquatic or plant
662	1132		life, and the disposal of which materials is controlled by state or
663	1133		federal guidelines;
664		-
665	1134		41. “Anhydrous ammonia” means any substance that exhibits
666	1135		cryogenic evaporative behavior and tests positive for ammonia;
667		-
668	1136		42. “Acute pain” means pain, whether resulting from disease,
669	1137		accidental or intentional trauma or other cause, that the
670	1138		practitioner reasonably expects to last only a short period of time.
671	1139		“Acute pain” Acute pain does not include chronic pain, pain being
672	1140		treated as part of cancer care, hospice or other end-of-life care,
673	1141		or pain being treated as part of palliative care;
674		-
675	1142		43. “Chronic pain” means pain that persists beyond the usual
676	1143		course of an acute disease or healing of an injury. “Chronic pain”
677	1144		Chronic pain may or may not be associated with an acute or chronic
678	1145		pathologic process that causes continuous or intermittent pain over
679	1146		months or years;
680		-
681	1147		44. “Initial prescription” means a prescription issued to a
682	1148		patient who:
683		-
684	1149		a. has never previously been issued a prescription for
685	1150		the drug or its pharmaceutical equivalent in the past
686	1151		year, or
	1152	+
	1153	+	ENGR. H. A. to ENGR. S. B. NO. 475 Page 23 1
	1154	+	2
	1155	+	3
	1156	+	4
	1157	+	5
	1158	+	6
	1159	+	7
	1160	+	8
	1161	+	9
	1162	+	10
	1163	+	11
	1164	+	12
	1165	+	13
	1166	+	14
	1167	+	15
	1168	+	16
	1169	+	17
	1170	+	18
	1171	+	19
	1172	+	20
	1173	+	21
	1174	+	22
	1175	+	23
	1176	+	24
687	1177
688	1178		b. requires a prescription for the drug or its
689	1179		pharmaceutical equivalent due to a surgica l procedure
690	1180		or new acute event and has previously had a
691	1181		prescription for the drug or its pharmaceutical
692	1182		equivalent within the past year.
693		-
694	1183		When determining whether a patient was previously issued a
695	1184		prescription for a drug or its pharmaceutical equivalent, th e
696	1185		practitioner shall consult with the patient and review the medical
697	1186		record and prescription monitoring information of the patient;
698		-
699	1187		45. “Patient-provider agreement” means a written contract or
700	1188		agreement that is executed between a practitioner and a patien t,
701		-
702		-	ENR. S. B. NO. 475 Page 17
703	1189		prior to the commencement of treatment for chronic pain using an
704	1190		opioid drug as a means to:
705		-
706	1191		a. explain the possible risk of development of physical
707	1192		or psychological dependence in the patient and prevent
708	1193		the possible development of addiction,
709		-
710	1194		b. document the understanding of both the practitioner
711	1195		and the patient regarding the patient-provider
712	1196		agreement of the patient,
713		-
714	1197		c. establish the rights of the patient in association
715	1198		with treatment and the obligations of the patient in
716	1199		relation to the responsible use, discontinuation of
717	1200		use, and storage of opioid drugs, including any
	1201	+
	1202	+	ENGR. H. A. to ENGR. S. B. NO. 475 Page 24 1
	1203	+	2
	1204	+	3
	1205	+	4
	1206	+	5
	1207	+	6
	1208	+	7
	1209	+	8
	1210	+	9
	1211	+	10
	1212	+	11
	1213	+	12
	1214	+	13
	1215	+	14
	1216	+	15
	1217	+	16
	1218	+	17
	1219	+	18
	1220	+	19
	1221	+	20
	1222	+	21
	1223	+	22
	1224	+	23
	1225	+	24
	1226	+
718	1227		restrictions on the refill of prescriptions or the
719	1228		acceptance of opioid prescriptions from practitioners,
720		-
721	1229		d. identify the specific medications and other modes of
722	1230		treatment, including physical therapy or exercise,
723	1231		relaxation or psychological counseling, that are
724	1232		included as a part of the patient-provider agreement,
725		-
726	1233		e. specify the measures the practitioner may employ to
727	1234		monitor the compliance of the patient including, but
728	1235		not limited to, rand om specimen screens and pill
729	1236		counts, and
730		-
731	1237		f. delineate the process for terminating the agreement,
732	1238		including the consequences if the practitioner has
733	1239		reason to believe that the patient is not complying
734	1240		with the terms of the agreement. Compliance with the
735	1241		“consent items” shall constitute a valid, informed
736	1242		consent for opioid therapy. The practitioner shall be
737	1243		held harmless from civil litigation for failure to
738	1244		treat pain if the event occurs because of nonadherence
739	1245		by the patient with any of the provisions of the
740	1246		patient-provider agreement;
741		-
742	1247		46. “Serious illness” means a medical illness or physical
743	1248		injury or condition that substantially affects quality of life for
744	1249		more than a short period of time. “Serious illness” Serious illness
745		-
746		-	ENR. S. B. NO. 475 Page 18
747	1250		includes, but is not limited to, Alzheimer’s disease or related
	1251	+
	1252	+	ENGR. H. A. to ENGR. S. B. NO. 475 Page 25 1
	1253	+	2
	1254	+	3
	1255	+	4
	1256	+	5
	1257	+	6
	1258	+	7
	1259	+	8
	1260	+	9
	1261	+	10
	1262	+	11
	1263	+	12
	1264	+	13
	1265	+	14
	1266	+	15
	1267	+	16
	1268	+	17
	1269	+	18
	1270	+	19
	1271	+	20
	1272	+	21
	1273	+	22
	1274	+	23
	1275	+	24
	1276	+
748	1277		dementias, lung disease, cancer, heart failure, renal failure, liver
749	1278		failure or chronic, unremitting or intractable pain such as
750	1279		neuropathic pain; and
751		-
752	1280		47. “Surgical procedure” means a procedure that is performed
753	1281		for the purpose of structurally altering the human body by incision
754	1282		or destruction of tissues as part of the practice of medicine. This
755	1283		term includes the diagnostic or therapeutic treatment of conditions
756	1284		or disease processes by use of instruments such as lasers,
757	1285		ultrasound, ionizing, radiation, scalpels, probes or needles that
758	1286		cause localized alteration or transportation of live human tissue by
759	1287		cutting, burning, vaporizing, freezing, suturing, probing or
760	1288		manipulating by closed reduction for major dislocations or
761	1289		fractures, or otherwise altering by any mechanical, thermal, light-
762	1290		based, electromagnetic or chemical means.
763		-
764	1291		SECTION 2. AMENDATORY 63 O.S. 2021, Section 2-110, is
765	1292		amended to read as follows:
766		-
767	1293		Section 2-110. The Director of the Oklahoma State Bureau of
768	1294		Narcotics and Dangerous Drugs Control may empl oy attorneys, who
769	1295		shall be unclassified employees of the state, or contract with
770	1296		attorneys, as needed. These attorneys may advise the Director, the
771	1297		Oklahoma State Bureau of Narcotics and Dangerous Drugs Control
772	1298		Commission and Bureau personnel on all legal matters and shall
773	1299		appear for and represent the Director, the Commission and Bureau
774	1300		personnel in all administrative hearings and all litigation or other
	1301	+
	1302	+	ENGR. H. A. to ENGR. S. B. NO. 475 Page 26 1
	1303	+	2
	1304	+	3
	1305	+	4
	1306	+	5
	1307	+	6
	1308	+	7
	1309	+	8
	1310	+	9
	1311	+	10
	1312	+	11
	1313	+	12
	1314	+	13
	1315	+	14
	1316	+	15
	1317	+	16
	1318	+	17
	1319	+	18
	1320	+	19
	1321	+	20
	1322	+	21
	1323	+	22
	1324	+	23
	1325	+	24
	1326	+
775	1327		proceedings which may arise in the discharge of their duties. At
776	1328		the request of the Oklahoma State Bur eau of Narcotics and Danger ous
777	1329		Drugs Control Commission, such attorney shall assist the distri ct
778	1330		attorney or the Attorney General in prosecuting charges of vi olators
779	1331		of the Uniform Controlled Dangerous Substances Act or any felony
780	1332		relating to or arising fr om a violation of the Unifo rm Controlled
781	1333		Dangerous Substances Act. Attorneys for the Bureau w ho have been
782	1334		certified by the Council on Law Enforcement Educati on and Training
783	1335		to carry a weapon or have been issued a handgun license pursuant to
784	1336		the provisions of the Oklahoma Self -Defense Act shall be allowed to
785	1337		carry weapons pursuant to paragraph 3 of subsection A of Section
786	1338		1272 of Title 21 of the Oklahoma Statut es. These attorneys,
787	1339		pursuant to this provision, shall not be considered eligible to
788	1340		participate in the Oklahoma Law Enforce ment Retirement System. If a
789		-
790		-	ENR. S. B. NO. 475 Page 19
791	1341		conflict of interest would be created by such attorney representing
792	1342		the Director, the Commission or B ureau personnel, additional counsel
793	1343		may be hired upon approval of the Oklahoma State Bureau of Nar cotics
794	1344		and Dangerous Drugs Control Commission.
795		-
796	1345		SECTION 3. AMENDATORY 63 O.S. 2021, Section 2-304, is
797	1346		amended to read as follows:
798		-
799	1347		Section 2-304. A. A registration, pursuant to Section 2-303 of
800	1348		this title, to manufacture, distribute, dispense, prescribe,
801	1349		administer or use for scientific purposes a controlled dan gerous
802	1350		substance shall be limited, conditioned, denied, suspended,
	1351	+
	1352	+	ENGR. H. A. to ENGR. S. B. NO. 475 Page 27 1
	1353	+	2
	1354	+	3
	1355	+	4
	1356	+	5
	1357	+	6
	1358	+	7
	1359	+	8
	1360	+	9
	1361	+	10
	1362	+	11
	1363	+	12
	1364	+	13
	1365	+	14
	1366	+	15
	1367	+	16
	1368	+	17
	1369	+	18
	1370	+	19
	1371	+	20
	1372	+	21
	1373	+	22
	1374	+	23
	1375	+	24
	1376	+
803	1377		annulled, or revoked by the Director of the Oklahoma State Bureau of
804	1378		Narcotics and Dangerous Dr ugs Control upon a finding that the
805	1379		registrant:
806		-
807	1380		1. Has materially falsified any application filed pursua nt to
808	1381		the Uniform Controlled Dangerous Substances Act or require d by the
809	1382		Uniform Controlled Dangerous Substanc es Act. It shall be unlawful
810	1383		to knowingly and willfully:
811		-
812	1384		a. make false statements, include false data or omit
813	1385		material information on an applicat ion for a
814	1386		registration with the Oklahoma State Bureau of
815	1387		Narcotics and Dangerous Drugs Control, or
816		-
817	1388		b. provide false data or omit material information in any
818	1389		records or reports required by rule or law to be
819	1390		created, maintained or submitted to the Bureau .
820		-
821	1391		Any registrant or applicant for a registration or any official,
822	1392		agent or employee of any registrant or applicant for a registration
823	1393		who violates the provisions of this paragraph shall be guilty of a
824	1394		misdemeanor and additionally subject to administrative acti on;
825		-
826	1395		2. Has been found guilty of, entered a plea of guilty or
827	1396		entered a plea of nolo contendere to a misdemean or relating to any
828	1397		substance defined herein as a controlled dangerous substance or any
829	1398		felony under the laws of any state or the United States;
830		-
831	1399		3. Has had his or her federal registration retired, suspended
832	1400		or revoked by a competent federal authority and i s no longer
833	1401
834		-	ENR. S. B. NO. 475 Page 20
	1402	+	ENGR. H. A. to ENGR. S. B. NO. 475 Page 28 1
	1403	+	2
	1404	+	3
	1405	+	4
	1406	+	5
	1407	+	6
	1408	+	7
	1409	+	8
	1410	+	9
	1411	+	10
	1412	+	11
	1413	+	12
	1414	+	13
	1415	+	14
	1416	+	15
	1417	+	16
	1418	+	17
	1419	+	18
	1420	+	19
	1421	+	20
	1422	+	21
	1423	+	22
	1424	+	23
	1425	+	24
	1426	+
835	1427		authorized by federal la w to manufacture, distribute, dispense,
836	1428		prescribe, administer or use for scientific purposes controlled
837	1429		dangerous substances;
838		-
839	1430		4. Has failed to maintain effective controls ag ainst the
840	1431		diversion of controlled dangerous su bstances to unauthorized persons
841	1432		or entities;
842		-
843	1433		5. Has prescribed, dispensed or administered a controlled
844	1434		dangerous substance from schedules other than those specified in his
845	1435		or her state or federal registration ;
846		-
847	1436		6. Has had a restriction, suspension, revoc ation, limitation,
848	1437		condition or probation placed on his or her professional license or
849	1438		certificate or practice as a result of a proceeding pursuan t to the
850	1439		general statutes;
851		-
852	1440		7. Is abusing or, within the past fi ve (5) years, has abused or
853	1441		excessively used drugs or controlled dangerous sub stances;
854		-
855	1442		8. Has prescribed, sold, administered or ordered any controlled
856	1443		substance for an immediate family member , himself or herself;
857	1444		provided that this shall not apply to a me dical emergency when no
858	1445		other doctor is availa ble to respond to the emergency ;
859		-
860	1446		9. Has possessed, used, prescribed, dispensed or administered
861	1447		drugs or controlled dangerous substances for other than legitimate
862	1448		medical or scientific purposes or for purposes outside the normal
863	1449		course of his or her profes sional practice;
	1450	+
	1451	+	ENGR. H. A. to ENGR. S. B. NO. 475 Page 29 1
	1452	+	2
	1453	+	3
	1454	+	4
	1455	+	5
	1456	+	6
	1457	+	7
	1458	+	8
	1459	+	9
	1460	+	10
	1461	+	11
	1462	+	12
	1463	+	13
	1464	+	14
	1465	+	15
	1466	+	16
	1467	+	17
	1468	+	18
	1469	+	19
	1470	+	20
	1471	+	21
	1472	+	22
	1473	+	23
	1474	+	24
864	1475
865	1476		10. Has been under the influence of alcohol or another
866	1477		intoxicating substance which adversely affected the central nervous
867	1478		system, vision, hearing or other sensory or motor functioning to
868	1479		such degree the person was impaired during the per formance of his or
869	1480		her job; or
870		-
871	1481		11. Has violated any federal law relating to any controlled
872	1482		substances, any provision of the Uniform Controlled Da ngerous
873	1483		Substances Act or any rules of the Oklahoma State Bureau of
874	1484		Narcotics and Dangerous Drugs Control.
875		-
876		-
877		-	ENR. S. B. NO. 475 Page 21
878	1485		B. In the event the Director suspends or revokes a registration
879	1486		granted under Section 2-303 of this title, all controlled dangerous
880	1487		substances owned or possessed by the registrant pursuant to such
881	1488		registration at the time of denial revocation or suspension or the
882	1489		effective date of the revocation order, as the case may be, may in
883	1490		the discretion of the Director be impounded and preserved . All
884	1491		controlled dangerous substances not impounded or preserved by the
885	1492		Director shall be maintained by the registrant . No disposition,
886	1493		purchase, distribution , sale, or transfer may be made of substances
887	1494		impounded and preserved until the time for taking an appeal has
888	1495		elapsed or until all appeals have been concluded unless a court,
889	1496		upon application therefor, orders the sale of p erishable substances
890	1497		and the deposit of the proceeds of the sale with the court. Upon a
891	1498		revocation order becoming final, all such co ntrolled dangerous
892	1499		substances shall be forfeited to the state or otherwise considered
	1500	+
	1501	+	ENGR. H. A. to ENGR. S. B. NO. 475 Page 30 1
	1502	+	2
	1503	+	3
	1504	+	4
	1505	+	5
	1506	+	6
	1507	+	7
	1508	+	8
	1509	+	9
	1510	+	10
	1511	+	11
	1512	+	12
	1513	+	13
	1514	+	14
	1515	+	15
	1516	+	16
	1517	+	17
	1518	+	18
	1519	+	19
	1520	+	20
	1521	+	21
	1522	+	22
	1523	+	23
	1524	+	24
	1525	+
893	1526		waste and submitted to a licensed was te disposal service for
894	1527		destruction pursuant to Section 430 of this title.
895		-
896	1528		C. The Drug Enforcement Administration shall promptly be
897	1529		notified of all orders suspending or revoking registration and all
898	1530		forfeitures of controlled dangerous substances.
899		-
900	1531		D. In lieu of or in addition to any other remed ies available to
901	1532		the Director, if a finding is made that a registrant has committed
902	1533		any act in violation o f federal law relating to any controlled
903	1534		substance, any provisio n of the Uniform Controlled Dangerous
904	1535		Substances Act or any rules of the Oklahoma Stat e Bureau of
905	1536		Narcotics and Dangerous Drugs Control, the Director is hereby
906	1537		authorized to assess an administ rative penalty not to exceed Two
907	1538		Thousand Dollars ($2,000.00) fo r each such act. The provisions of
908	1539		this subsection shall not apply to violations of s ubsection G of
909	1540		Section 2-309D of this title. Nothing in this section shall be
910	1541		construed so as to permit t he Director of the State Bureau of
911	1542		Narcotics and Dangerous Drugs Control to assess administrative fines
912	1543		for violations of the provisions of subsection G of Section 2-309D
913	1544		of this title.
914		-
915	1545		SECTION 4. AMENDATORY 63 O.S. 2021, Section 2-305, is
916	1546		amended to read as follows:
917		-
918	1547		Section 2-305. A. Before denying, suspending or revoking a
919	1548		registration, refusing a renewal of registration or taking
920		-
921		-	ENR. S. B. NO. 475 Page 22
922	1549		administrative action on a n onregistrant engaged in manufacturing,
	1550	+
	1551	+	ENGR. H. A. to ENGR. S. B. NO. 475 Page 31 1
	1552	+	2
	1553	+	3
	1554	+	4
	1555	+	5
	1556	+	6
	1557	+	7
	1558	+	8
	1559	+	9
	1560	+	10
	1561	+	11
	1562	+	12
	1563	+	13
	1564	+	14
	1565	+	15
	1566	+	16
	1567	+	17
	1568	+	18
	1569	+	19
	1570	+	20
	1571	+	21
	1572	+	22
	1573	+	23
	1574	+	24
	1575	+
923	1576		distributing, dispensing, presc ribing, administering or using for
924	1577		scientific purposes any controlled dangerous substance within or
925	1578		into this state, the Director shall serve upon the applicant or
926	1579		registrant an order to show cause why registration should not be
927	1580		denied, revoked or suspended or why the renewal should not be
928	1581		refused. The order to show cause shall contain a statement of the
929	1582		basis therefor and shall call upon the applicant or registrant to
930	1583		appear before the appropriate person or agency at a time and place
931	1584		within thirty (30) days after the date of service of the order, but
932	1585		in the case of a denial or renewal of registration the sho w cause
933	1586		order shall be served within thirty ( 30) days before the expiration
934	1587		of the registration. These proceedings shall be conducted in
935	1588		accordance with the Administrative Procedures Act without regard to
936	1589		any criminal prosecution or other proceeding . Proceedings to refuse
937	1590		renewal of registration sh all not abate the existing registr ation
938	1591		which shall remain in effect pending the outcome of the
939	1592		administrative hearing In addition to any other remedies provided
940	1593		for by law, the Director shall issue a written order to be served on
941	1594		the parties before annull ing, conditioning, suspending or revoking
942	1595		any registration that the Director has reason to believe is
943	1596		operating inconsistent with any provision of Section 2-303 of this
944	1597		title, pursuant to Section 2-304 of this title or otherwise where
945	1598		there has been a violation of any federal law , any rule or
946	1599		regulation of the Drug Enforcement Administration, any provision of
	1600	+
	1601	+	ENGR. H. A. to ENGR. S. B. NO. 475 Page 32 1
	1602	+	2
	1603	+	3
	1604	+	4
	1605	+	5
	1606	+	6
	1607	+	7
	1608	+	8
	1609	+	9
	1610	+	10
	1611	+	11
	1612	+	12
	1613	+	13
	1614	+	14
	1615	+	15
	1616	+	16
	1617	+	17
	1618	+	18
	1619	+	19
	1620	+	20
	1621	+	21
	1622	+	22
	1623	+	23
	1624	+	24
	1625	+
947	1626		the Uniform Controlled Dangerous Substances Act, or any rules or
948	1627		regulations of the Oklahoma State Bureau of N arcotics and Dangerous
949	1628		Drugs Control.
950		-
951	1629		B. The Director shall suspend , without an order to show cause,
952	1630		any registration simultaneously with the institution of proceedings
953	1631		under Section 2-304 of this title, if h e or she finds there is
954	1632		imminent danger to the public health or safety which warrants this
955	1633		action. The suspension shall continue in effect until the
956	1634		conclusion of the proceedings, including judicial review thereof,
957	1635		unless sooner withdrawn by the Director or dissolved by a court of
958	1636		competent jurisdicti on The written order shall state with
959	1637		specificity the nature of the violation or basis for the action.
960	1638		The Director may impose any disciplinary action authorized by the
961	1639		Uniform Controlled Dangerous Substances Act or rules of the Oklahoma
962	1640		State Bureau of Narcotics and Dangerous Drugs Control including, but
963	1641		not limited to, the assessment of monetary penalties.
964		-
965		-	ENR. S. B. NO. 475 Page 23
966		-
967	1642		C. Any written order issued pursuant to the provisions of this
968	1643		section shall become a final order unles s the registrant requests an
969	1644		administrative hearing in accordance with the rules and regulations
970	1645		promulgated by the Director within thirty (30) days of issuance.
971	1646		Upon such request, the Director shall promptly initiate
972	1647		administrative proceedings and serve formal notice of the
973	1648		proceedings pursuant to S ection 309 of Title 75 of the Oklahoma
974	1649		Statutes. Nothing in this section shall be construed so as to
	1650	+
	1651	+	ENGR. H. A. to ENGR. S. B. NO. 475 Page 33 1
	1652	+	2
	1653	+	3
	1654	+	4
	1655	+	5
	1656	+	6
	1657	+	7
	1658	+	8
	1659	+	9
	1660	+	10
	1661	+	11
	1662	+	12
	1663	+	13
	1664	+	14
	1665	+	15
	1666	+	16
	1667	+	17
	1668	+	18
	1669	+	19
	1670	+	20
	1671	+	21
	1672	+	22
	1673	+	23
	1674	+	24
	1675	+
975	1676		require an individual proceeding for the denial of a new application
976	1677		for registration.
977		-
978	1678		D. The Director may authorize the Deputy Director or the
979	1679		General Counsel of the Oklahoma State Bureau of Narcotics and
980	1680		Dangerous Drugs Control to initiate any individual proceedings under
981	1681		this title. Nothing in this section shall be construed so as to
982	1682		delegate the authority of the Director to issue a final agency order
983	1683		adverse to a party.
984		-
985	1684		E. All proceedings shall be conducted in accord ance with the
986	1685		Administrative Procedures Act and the rules and regulations of the
987	1686		Oklahoma State Bureau of Narcotics and Dangerous Drugs Contro l
988	1687		without regard to any criminal prosecution o r other proceeding.
989	1688		Proceedings to refuse renewal, revoke, or suspend a registration
990	1689		shall not abate the existing registration which shall remain in
991	1690		effect pending the outcome of those administrative proceedin gs.
992	1691		This abatement shall not apply when the D irector finds there is an
993	1692		imminent danger to the public hea lth or safety requir ing an
994	1693		immediate suspension.
995		-
996	1694		The Director may delegate to an administrative hearing officer
997	1695		the authority to conduct hearings and r ecommend action for final
998	1696		agency orders in acc ordance with the rules and regulations of the
999	1697		Oklahoma State Bureau of Narcotic s and Dangerous Drugs Control.
1000		-
1001	1698		F. The Director may issue an order immediately suspending a
1002	1699		registration, without notice or a heari ng, when he or she finds
	1700	+
	1701	+	ENGR. H. A. to ENGR. S. B. NO. 475 Page 34 1
	1702	+	2
	1703	+	3
	1704	+	4
	1705	+	5
	1706	+	6
	1707	+	7
	1708	+	8
	1709	+	9
	1710	+	10
	1711	+	11
	1712	+	12
	1713	+	13
	1714	+	14
	1715	+	15
	1716	+	16
	1717	+	17
	1718	+	18
	1719	+	19
	1720	+	20
	1721	+	21
	1722	+	22
	1723	+	23
	1724	+	24
	1725	+
1003	1726		there is imminent dan ger to the public health or safety which
1004	1727		warrants this action. The suspension shall continue in effect until
1005	1728		the conclusion of any administrative proceedings, including judicial
1006	1729		review thereof, unless sooner w ithdrawn by the Director or dissolved
1007	1730		by a court of competent jurisdiction. The order shall state the
1008		-
1009		-	ENR. S. B. NO. 475 Page 24
1010	1731		existence of an emerge ncy requiring action be taken that the
1011	1732		Director deems necessary to meet the emergency. Such action may
1012	1733		include, but is not limited to, ordering the registrant to
1013	1734		immediately cease and desist operations. The order shall be
1014	1735		effective immediately upon issua nce. Any person to whom the order
1015	1736		is directed shall comply immediately with the provisions of the
1016	1737		order. The Director may assess a penalty not to exceed Ten Thousand
1017	1738		Dollars ($10,000.00) per day of noncompliance with the order. In
1018	1739		assessing such a penal ty, the Director shall consider the
1019	1740		seriousness of the violation and any efforts to comply with
1020	1741		applicable requirements. Upon application to the Director, the
1021	1742		registrant shall be offered a hearing within thirty (30) days of the
1022	1743		issuance of the order.
1023		-
1024	1744		G. In lieu of or in addition to any other remedies available to
1025	1745		the Director, if a finding is made that a registrant has committed
1026	1746		any act in violation of federal law relating to a ny controlled
1027	1747		substance, any provision of the Uniform Contr olled Dangerous
1028	1748		Substances Act or any rules of the Oklahoma State Bureau of
1029	1749		Narcotics and Dangerous Drugs Control, the Director is hereby
	1750	+
	1751	+	ENGR. H. A. to ENGR. S. B. NO. 475 Page 35 1
	1752	+	2
	1753	+	3
	1754	+	4
	1755	+	5
	1756	+	6
	1757	+	7
	1758	+	8
	1759	+	9
	1760	+	10
	1761	+	11
	1762	+	12
	1763	+	13
	1764	+	14
	1765	+	15
	1766	+	16
	1767	+	17
	1768	+	18
	1769	+	19
	1770	+	20
	1771	+	21
	1772	+	22
	1773	+	23
	1774	+	24
	1775	+
1030	1776		authorized to assess an administrative penalty not to excee d Five
1031	1777		Thousand Dollars ($5,000.00) per day for each such a ct. The
1032	1778		provisions of this subsection shall not apply to violations of
1033	1779		subsection G of Section 2-309D of this title. Nothing in this
1034	1780		section shall be construed so as to permit the Director of the
1035	1781		Oklahoma State Bureau of Narcotics and Dangerous Drugs Control to
1036	1782		assess administrative fines for violations of the provisions of
1037	1783		subsection G of Section 2-309D of this title.
1038		-
1039	1784		If a judge of competent jurisdiction finds probable cau se that a
1040	1785		registrant has possesse d, transferred, sold, or offered for sale any
1041	1786		controlled dangerous substance in violation of this act, all
1042	1787		controlled dangerous substances in Schedule I of Section 2-204 of
1043	1788		this title and all controlled dangerous substances in Schedu les II,
1044	1789		III, IV, and V that are n ot in properly labeled containers in
1045	1790		accordance with this a ct then in the posse ssion of the registrant
1046	1791		shall be deemed contraband and shall be seized and summarily
1047	1792		forfeited pursuant to Section 2-505 of this title. Samples shall be
1048	1793		retained of all control led dangerous substances seized in accordance
1049	1794		with Section 2-508 of this title as required. The Director is
1050	1795		authorized to assess an eradication or destruction fine not to
1051	1796		exceed Fifty Thousand Dollars ($50,000.00) against the registrant.
1052		-
1053		-	ENR. S. B. NO. 475 Page 25
1054		-
1055	1797		H. Upon an annulment, revocation, or denial of a registration
1056	1798		the Director may prohibit the reg istrant or applicant from
1057	1799		reapplying for registration for a period up to five years following
	1800	+
	1801	+	ENGR. H. A. to ENGR. S. B. NO. 475 Page 36 1
	1802	+	2
	1803	+	3
	1804	+	4
	1805	+	5
	1806	+	6
	1807	+	7
	1808	+	8
	1809	+	9
	1810	+	10
	1811	+	11
	1812	+	12
	1813	+	13
	1814	+	14
	1815	+	15
	1816	+	16
	1817	+	17
	1818	+	18
	1819	+	19
	1820	+	20
	1821	+	21
	1822	+	22
	1823	+	23
	1824	+	24
	1825	+
1058	1826		the date of the final order. The length of any pr ohibition shall
1059	1827		not be used as grounds to contest the validity of the annulment,
1060	1828		revocation, or denial of a registration.
1061		-
1062		-	SECTION 5. AMENDATORY 63 O.S. 2021, Section 2-322, as
1063		-	last amended by Section 1 of Enrolled Senate Bill No . 668 of the 1st
1064		-	Session of the 59th Oklahoma Legislature, is amended to read as
1065		-	follows:
1066		-
	1829	+	SECTION 5. AMENDATORY 63 O.S. 2021, Section 2-322, is
	1830	+	amended to read as follows:
1067	1831		Section 2-322. A. No person or business shall possess, se ll,
1068	1832		manufacture, transfer, or otherwise furnish any of the following
1069	1833		precursor substances without first having a permit or license issued
1070	1834		by the Director of the Oklahoma State Bureau of Narcotics and
1071	1835		Dangerous Drugs Control , except as provided in Section 2 -327 of this
1072	1836		title:
1073		-
1074	1837		1. D-Lysergic acid;
1075		-
1076	1838		2. Ergotamine and its salts;
1077		-
1078	1839		3. Ergonovine and its salts;
1079		-
1080	1840		4. Methylamine;
1081		-
1082	1841		5. Ethylamine;
1083		-
1084	1842		6. Phenyl-2-Propanone;
1085		-
1086	1843		7. Phenylacetic acid and its salts;
1087		-
1088		-	8. Norpseudoephedrine, its salts, optical isomers, and salts of
	1844	+	8. Ephedrine, its salts, op tical isomers and salts of optica l
	1845	+	isomers;
	1846	+	9. Norpseudoephedrine, its salts, optical isomers, and salts of
1089	1847		optical isomers;
1090		-
1091		-	9. Benzyl cyanide;
1092		-
1093		-	10. N-methylephedrine, its salts, optical isomers , and salts of
	1848	+	10. Phenylpropanolamine, its salts, optical isomers and salts
	1849	+	of optical isomers;
	1850	+
	1851	+	ENGR. H. A. to ENGR. S. B. NO. 475 Page 37 1
	1852	+	2
	1853	+	3
	1854	+	4
	1855	+	5
	1856	+	6
	1857	+	7
	1858	+	8
	1859	+	9
	1860	+	10
	1861	+	11
	1862	+	12
	1863	+	13
	1864	+	14
	1865	+	15
	1866	+	16
	1867	+	17
	1868	+	18
	1869	+	19
	1870	+	20
	1871	+	21
	1872	+	22
	1873	+	23
	1874	+	24
	1875	+
	1876	+	11. Benzyl cyanide;
	1877	+	12. N-methylephedrine, its salts, optical isomers and salt s of
1094	1878		optical isomers;
1095		-
1096		-
1097		-	ENR. S. B. NO. 475 Page 26
1098		-	11. Chloroephedrine, its salts, optical isomers, and salts of
	1879	+	13. Pseudoephedrine, its salts, optical isomers and salts of
1099	1880		optical isomers;
1100		-
1101		-	12. Piperidine and its salts;
1102		-
1103		-	13. Pyrrolidine and its salts;
1104		-
1105		-	14. Propionic anhydride;
1106		-
1107		-	15. Isosafrole;
1108		-
1109		-	16. Safrole;
1110		-
1111		-	17. Piperonal; and
1112		-
1113		-	18. Red Phosphorus.
1114		-
	1881	+	14. Chloroephedrine, its salts, optical isomers and salts of
	1882	+	optical isomers;
	1883	+	15. Piperidine and its salts;
	1884	+	16. Pyrrolidine and its salts;
	1885	+	17. Propionic anhydride;
	1886	+	18. Isosafrole;
	1887	+	19. Safrole;
	1888	+	20. Piperonal; and
	1889	+	21. Red Phosphorus.
1115	1890		B. Upon completion of an application for a license pursuant to
1116	1891		Section 2-323 of this title, or a permit pursuant to Section 2 -324
1117	1892		of this title, the Director of the Oklah oma State Bureau of
1118	1893		Narcotics and Dangerous Drugs Control shall either grant or deny
1119	1894		such license or permit. A denial of an application for a permit or
1120	1895		license shall be handled as provided by Section 2-325 of this title.
1121		-
1122		-	SECTION 6. AMENDATORY 63 O.S. 2021, Section 2 -325, as
1123		-	last amended by Section 3 of Enrolled H ouse Bill No. 2282 of the 1st
1124		-	Session of the 59th Oklahoma Legislature, is amended to read as
1125		-	follows:
1126		-
	1896	+	SECTION 6. AMENDATORY 63 O.S. 2021, Section 2 -325, is
	1897	+	amended to read as follows:
1127	1898		Section 2-325. A. A license or permit, obtained pursuant to
1128		-	Section 2-323 or 2-324 of this title, shall be annulled, suspended,
1129		-	or revoked by the Director u pon finding that the licensee or pe rmit
1130		-	holder has:
1131		-
	1899	+	Sections 5 Section 2-323 or 6 2-324 of this act title, shall be
	1900	+
	1901	+	ENGR. H. A. to ENGR. S. B. NO. 475 Page 38 1
	1902	+	2
	1903	+	3
	1904	+	4
	1905	+	5
	1906	+	6
	1907	+	7
	1908	+	8
	1909	+	9
	1910	+	10
	1911	+	11
	1912	+	12
	1913	+	13
	1914	+	14
	1915	+	15
	1916	+	16
	1917	+	17
	1918	+	18
	1919	+	19
	1920	+	20
	1921	+	21
	1922	+	22
	1923	+	23
	1924	+	24
	1925	+
	1926	+	denied annulled, suspended, or revoked by the Director u pon finding
	1927	+	that the licensee or pe rmit holder has:
1132	1928		1. Materially falsified any application filed pursuant to this
1133	1929		act Section 2-321 et seq. of this title or required by this act the
1134	1930		Precursor Substances Act;
1135		-
1136	1931		2. Been convicted of a misdemeanor relating t o any precursor
1137		-	substance defined in Section 2-322 of this title or any felony under
1138		-	the laws of this state or the United States; or
1139		-
1140		-
1141		-	ENR. S. B. NO. 475 Page 27
	1932	+	substance defined in Section 4 2-322 of this act title or any felony
	1933	+	under the laws of this state or the United States; or
1142	1934		3. Failed to maintain effective controls against the diversion
1143	1935		of said the precursors to unauthorized persons or ent ities.
1144		-
1145		-	B. Before annulling, suspending, or revoking a lice nse or
1146		-	permit, the Director shall cause to be ser ved upon the licensee or
1147		-	permit holder an order to show cause why a license or a permit
1148		-	should not be annulled, suspended, or revoked. The order to show
1149		-	cause shall contain a s tatement of the basis therefor and shall call
1150		-	upon the licensee or permit holder to appear before the appropriate
1151		-	person or agency at the time and place within sixty (60) days after
1152		-	the date of service of the order. The proceedings shall be
1153		-	conducted in accordance with the Administrative Pr ocedures Act
1154		-	without regard to any criminal prosecution or other proceeding.
1155		-	Nothing in this section shall be construed so as to require an
1156		-	individual proceeding for the denial of a new license or permit.
	1936	+	B. Before denying annulling, suspending, or revoking a lice nse
	1937	+	or permit, the Director shall cause to be ser ved upon the applicant,
	1938	+	licensee, or permit holder an order to show cause why a license or a
	1939	+	permit should not be denied annulled, suspended, or revoked. The
	1940	+	order to show cause shall contain a s tatement of the basis therefor
	1941	+	and shall call upon the applicant, licensee, or permit holder to
	1942	+	appear before the appropriate person or agency at the time and place
	1943	+	within thirty (30) sixty (60) days after the date of service of the
	1944	+	order. The proceedings shall be c onducted in accordance with the
	1945	+	Administrative Procedures Act without regard to any criminal
	1946	+	prosecution or other proceeding. Nothing in this section shall be
	1947	+	construed so as to require an individual proceeding for the denial
	1948	+	of a new license or permit.
	1949	+
	1950	+	ENGR. H. A. to ENGR. S. B. NO. 475 Page 39 1
	1951	+	2
	1952	+	3
	1953	+	4
	1954	+	5
	1955	+	6
	1956	+	7
	1957	+	8
	1958	+	9
	1959	+	10
	1960	+	11
	1961	+	12
	1962	+	13
	1963	+	14
	1964	+	15
	1965	+	16
	1966	+	17
	1967	+	18
	1968	+	19
	1969	+	20
	1970	+	21
	1971	+	22
	1972	+	23
	1973	+	24
1157	1974
1158	1975		C. The Director shall suspend, without an order t o show cause,
1159	1976		any license or permit simultaneously with the institution of
1160		-	proceedings described in subsection B of this section if the
1161		-	Director finds there is imminent danger to the public health or
1162		-	safety which warrants this action. The suspension shall continue in
1163		-	effect until the conclusion of the proceedings, including judicial
1164		-	review thereof, unless withdrawn by the Director or dissolved by a
1165		-	court of competent jurisdiction.
1166		-
	1977	+	proceedings described in subsect ion B of this section if he finds
	1978	+	there is imminent danger to the public health or safety which
	1979	+	warrants this action. The suspension shall continue in effect until
	1980	+	the conclusion of the proceedings, including judicial review
	1981	+	thereof, unless withdrawn by t he Director or dissolved by a cou rt of
	1982	+	competent jurisdiction.
1167	1983		SECTION 7. AMENDATORY 63 O.S. 2021, Section 2-406, is
1168	1984		amended to read as follows:
1169		-
1170	1985		Section 2-406. A. It shall be unlawful for any registrant
1171	1986		knowingly or intentionall y:
1172		-
1173	1987		1. To distribute, other than by dispensing or as otherwise
1174	1988		authorized by this act Section 2-101 et seq. of this title, a
1175	1989		controlled dangerous substance classified in Schedules I or II, in
1176	1990		the course of his legitimate business, except pursua nt to an order
1177	1991		form as required by Section 2 -308 of this title;
1178		-
1179	1992		2. To use in the course of the manu facture or distribution of a
1180	1993		controlled dangerous substance a registration number which is
1181	1994		fictitious, revoked, suspended or issued to another person;
1182		-
1183		-
1184		-	ENR. S. B. NO. 475 Page 28
1185	1995		3. To acquire or obtain possession of a controlle d dangerous
1186	1996		substance by misrepresentation, fraud, forg ery, deception or
1187	1997		subterfuge;
	1998	+
	1999	+	ENGR. H. A. to ENGR. S. B. NO. 475 Page 40 1
	2000	+	2
	2001	+	3
	2002	+	4
	2003	+	5
	2004	+	6
	2005	+	7
	2006	+	8
	2007	+	9
	2008	+	10
	2009	+	11
	2010	+	12
	2011	+	13
	2012	+	14
	2013	+	15
	2014	+	16
	2015	+	17
	2016	+	18
	2017	+	19
	2018	+	20
	2019	+	21
	2020	+	22
	2021	+	23
	2022	+	24
1188	2023
1189	2024		4. To furnish false or fraudulent material information in, o r
1190	2025		omit any material information from, any application, report, or
1191	2026		other document required to be kept or filed under this act, or any
1192	2027		record required to be kept by this act Section 2-101 et seq. of this
1193	2028		title; and
1194		-
1195	2029		5. To make, distribute, or possess any punch, die, plate,
1196	2030		stone, or other thing designed to print, imprint, or reproduce the
1197	2031		trademark, trade name, or other identifying mark, imprint, or device
1198	2032		of another or any likeness of any of the foregoing upon any drug or
1199	2033		container or labeling thereof so as to render such drug a
1200	2034		counterfeit controlled dangerous substance.
1201		-
1202	2035		B. Any person who violates this section is guilty of a felony
1203	2036		punishable by imprisonment for not more than twenty (20) years or a
1204	2037		fine of not more than Two Hu ndred Fifty Thousand Dollars
1205	2038		($250,000.00), or both.
1206		-
1207	2039		C. Any person convicted of a second or subsequent violation of
1208	2040		this section is punishable by a term of imprisonment twic e that
1209	2041		otherwise authorized and by twice the fine otherwise authorized.
1210	2042		Convictions for second or subsequent violations of this section
1211	2043		shall not be subject to statutory provisions for suspended
1212	2044		sentences, deferred sentences, or probation.
1213		-
	2045	+	D. Any person convicted of any offense described in this
	2046	+	section shall, in addition to any fine imposed, pay a special
	2047	+	assessment trauma-care fee of One Hundred Dollars ($100.00) to be
	2048	+
	2049	+	ENGR. H. A. to ENGR. S. B. NO. 475 Page 41 1
	2050	+	2
	2051	+	3
	2052	+	4
	2053	+	5
	2054	+	6
	2055	+	7
	2056	+	8
	2057	+	9
	2058	+	10
	2059	+	11
	2060	+	12
	2061	+	13
	2062	+	14
	2063	+	15
	2064	+	16
	2065	+	17
	2066	+	18
	2067	+	19
	2068	+	20
	2069	+	21
	2070	+	22
	2071	+	23
	2072	+	24
	2073	+
	2074	+	deposited into the Trauma Care Assistance Revolving Fund cr eated in
	2075	+	Section 1-2522 1-2530.9 of this title.
	2076	+	SECTION 8. It being immediately necessary for the pr eservation
	2077	+	of the public peace, health or safety, an emergency is hereby
	2078	+	declared to exist, by reason whereof this act shall take ef fect and
	2079	+	be in full force from and after its passage and approval."
	2080	+	Passed the House of Representatives the 24th day of April, 2023.
	2081	+
	2082	+
	2083	+
	2084	+
	2085	+
	2086	+	Presiding Officer of the House of
	2087	+	Representatives
	2088	+
	2089	+
	2090	+	Passed the Senate the ____ day of __________, 2023.
	2091	+
	2092	+
	2093	+
	2094	+
	2095	+
	2096	+	Presiding Officer of the Senate
	2097	+
	2098	+
	2099	+	ENGR. S. B. NO. 475 Page 1 1
	2100	+	2
	2101	+	3
	2102	+	4
	2103	+	5
	2104	+	6
	2105	+	7
	2106	+	8
	2107	+	9
	2108	+	10
	2109	+	11
	2110	+	12
	2111	+	13
	2112	+	14
	2113	+	15
	2114	+	16
	2115	+	17
	2116	+	18
	2117	+	19
	2118	+	20
	2119	+	21
	2120	+	22
	2121	+	23
	2122	+	24
	2123	+
	2124	+	ENGROSSED SENATE
	2125	+	BILL NO. 475 By: Paxton of the Senate
	2126	+
	2127	+	and
	2128	+
	2129	+	Echols of the House
	2130	+
	2131	+
	2132	+
	2133	+
	2134	+	An Act relating to the Uniform Controlled Dangerous
	2135	+	Substances Act; amending 63 O.S. 2021, Section 2-101,
	2136	+	as amended by Section 4, Chapte r 265, O.S.L. 2022 ( 63
	2137	+	O.S. Supp. 2022, Section 2 -101), which relates to
	2138	+	definitions; defining certain term; amending 63 O.S.
	2139	+	2021, Section 2-110, which relates to attorneys;
	2140	+	requiring certain attorneys to assist Attorney
	2141	+	General for specified purp oses; amending 63 O.S.
	2142	+	2021, Section 2-304, which relates to den ial,
	2143	+	revocation, or suspension of regi stration;
	2144	+	authorizing certain action; modifying certain
	2145	+	registration suspension and revocation guidelines;
	2146	+	removing certain administrative penalty
	2147	+	authorization; amending 63 O.S. 2021, Section 2-305,
	2148	+	which relates to the order to show cause; removing
	2149	+	certain order servicing guidelines; requiring certain
	2150	+	servicing guidelines; removing certain suspension
	2151	+	guidelines; requiring certain written order
	2152	+	guidelines; requiring certain final ord er guidelines;
	2153	+	requiring certain administrative proceedings
	2154	+	guidelines; permitting certain delegation authority;
	2155	+	prohibiting certain de legation authority; requiring
	2156	+	certain proceedings guidelines; creating certain
	2157	+	suspension exception; permitting certa in authority to
	2158	+	administrative hearing officers; permitting certain
	2159	+	suspensions; permitting certain assessed penalties ;
	2160	+	requiring certain hearing guideline; authorizing
	2161	+	certain assessed penalties; prohibiting certain
	2162	+	assessed fees; requiring certain seizures; requiring
	2163	+	certain sample retention; authorizing certain fines;
	2164	+	permitting the Director of the Oklahoma State Bureau
	2165	+	of Narcotics and Dangerous Drugs Control to prohibit
	2166	+	certain reapplication; requiring certain exemption ;
	2167	+	amending 63 O.S. 2021, Section 2 -322, which relates
	2168	+	to precursor substances requiring permit or license;
	2169	+	removing certain statutory reference; amending 63
	2170	+	O.S. 2021, Section 2 -325, which relates to denial,
	2171	+
	2172	+	ENGR. S. B. NO. 475 Page 2 1
	2173	+	2
	2174	+	3
	2175	+	4
	2176	+	5
	2177	+	6
	2178	+	7
	2179	+	8
	2180	+	9
	2181	+	10
	2182	+	11
	2183	+	12
	2184	+	13
	2185	+	14
	2186	+	15
	2187	+	16
	2188	+	17
	2189	+	18
	2190	+	19
	2191	+	20
	2192	+	21
	2193	+	22
	2194	+	23
	2195	+	24
	2196	+
	2197	+	revocation, or suspension of registra tion; modifying
	2198	+	certain requirement; requiring certain registration
	2199	+	guideline; amending 63 O.S. 2021, Section 2 -406,
	2200	+	which relates to penalties; adding certain unlawful
	2201	+	act; updating statutory reference s; updating
	2202	+	statutory language; and declaring an emergency.
	2203	+
	2204	+
	2205	+
	2206	+
	2207	+	BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
	2208	+	SECTION 9. AMENDATORY 63 O.S. 2021, Section 2-101, as
	2209	+	amended by Section 4, Ch apter 265, O.S.L. 2022 (63 O.S. Supp. 2022,
	2210	+	Section 2-101), is amended to read as foll ows:
	2211	+	Section 2-101. As used in the Uniform Controlled Dangerous
	2212	+	Substances Act:
	2213	+	1. “Administer” means the direct application of a controlled
	2214	+	dangerous substance, whether by injection, inhalation, ingestion or
	2215	+	any other means, to the body of a patient, animal or research
	2216	+	subject by:
	2217	+	a. a practitioner (or, in the presence of the
	2218	+	practitioner, by the authorized agent of the
	2219	+	practitioner), or
	2220	+	b. the patient or research subject at the direction and
	2221	+	in the presence of the practitioner;
	2222	+	2. “Agent” means a peace officer appointed by and who acts on
	2223	+	behalf of the Director of the Oklahoma State Bureau of Narcotics and
	2224	+	Dangerous Drugs Control or an authorized person who acts on behalf
	2225	+	of or at the direction of a person who manufactures, distributes,
	2226	+
	2227	+	ENGR. S. B. NO. 475 Page 3 1
	2228	+	2
	2229	+	3
	2230	+	4
	2231	+	5
	2232	+	6
	2233	+	7
	2234	+	8
	2235	+	9
	2236	+	10
	2237	+	11
	2238	+	12
	2239	+	13
	2240	+	14
	2241	+	15
	2242	+	16
	2243	+	17
	2244	+	18
	2245	+	19
	2246	+	20
	2247	+	21
	2248	+	22
	2249	+	23
	2250	+	24
	2251	+
	2252	+	dispenses, prescribes, administers or uses for scientific purposes
	2253	+	controlled dangerous substances but does not include a common or
	2254	+	contract carrier, public warehouser or employee thereof, or a person
	2255	+	required to register under the Uniform Controlled Dangerous
	2256	+	Substances Act;
	2257	+	3. “Board” means the Advisory Board to the Director of the
	2258	+	Oklahoma State Bureau of Narcotics and Dangerous Drugs Control;
	2259	+	4. “Bureau” means the Oklahoma State Bureau of Narcotics and
	2260	+	Dangerous Drugs Control;
	2261	+	5. “Coca leaves” includes cocaine and any compound,
	2262	+	manufacture, salt, derivative, mixture or preparation of coca
	2263	+	leaves, except derivatives of coca leaves which do not contain
	2264	+	cocaine or ecgonine;
	2265	+	6. “Commissioner” or “Director” means the Director of the
	2266	+	Oklahoma State Bureau of Narcotics and Dangerous Drugs Control;
	2267	+	7. “Control” means to add, remove or change the placement of a
	2268	+	drug, substance or immediate precursor under the Uniform Controlled
	2269	+	Dangerous Substances Act;
	2270	+	8. “Controlled dangerous substance” means a drug, substance or
	2271	+	immediate precursor in Schedules I through V of the Uniform
	2272	+	Controlled Dangerous Substances Act or any drug, substance or
	2273	+	immediate precursor listed either temporarily or permanently as a
	2274	+	federally controlled substance. Any conflict between state and
	2275	+
	2276	+	ENGR. S. B. NO. 475 Page 4 1
	2277	+	2
	2278	+	3
	2279	+	4
	2280	+	5
	2281	+	6
	2282	+	7
	2283	+	8
	2284	+	9
	2285	+	10
	2286	+	11
	2287	+	12
	2288	+	13
	2289	+	14
	2290	+	15
	2291	+	16
	2292	+	17
	2293	+	18
	2294	+	19
	2295	+	20
	2296	+	21
	2297	+	22
	2298	+	23
	2299	+	24
	2300	+
	2301	+	federal law with regard to the particular schedule in which a
	2302	+	substance is listed shall be resolved in favor of state law;
	2303	+	9. “Counterfeit substance” means a controlled substance which,
	2304	+	or the container or labeling of which without authorization, bears
	2305	+	the trademark, trade name or other identifying marks, imprint,
	2306	+	number or device or any likeness thereof of a manufacturer,
	2307	+	distributor or dispenser other than the person who in fact
	2308	+	manufactured, distributed or dispensed the substance;
	2309	+	10. “Deliver” or “delivery” means the actual, constructive or
	2310	+	attempted transfer from one person to another of a controlled
	2311	+	dangerous substance or drug paraphernalia, whether or not there is
	2312	+	an agency relationship;
	2313	+	11. “Dispense” means to deliver a controlled dangerous
	2314	+	substance to an ultimate user or human research subject by or
	2315	+	pursuant to the lawful order of a practitioner, including the
	2316	+	prescribing, administering, packaging, labeling or compounding
	2317	+	necessary to prepare the substance for such distribution.
	2318	+	“Dispenser” is a practitioner who delivers a controlled dangerous
	2319	+	substance to an ultimate user or human research subject;
	2320	+	12. “Distribute” means to deliver other than by administering
	2321	+	or dispensing a controlled dangerous substance;
	2322	+	13. “Distributor” means a commercial entity engaged in the
	2323	+	distribution or reverse distribution of narcotics and dangerous
	2324	+	drugs and who complies with all regulations promulgated by the
	2325	+
	2326	+	ENGR. S. B. NO. 475 Page 5 1
	2327	+	2
	2328	+	3
	2329	+	4
	2330	+	5
	2331	+	6
	2332	+	7
	2333	+	8
	2334	+	9
	2335	+	10
	2336	+	11
	2337	+	12
	2338	+	13
	2339	+	14
	2340	+	15
	2341	+	16
	2342	+	17
	2343	+	18
	2344	+	19
	2345	+	20
	2346	+	21
	2347	+	22
	2348	+	23
	2349	+	24
	2350	+
	2351	+	federal Drug Enforcement Administration and the Oklahoma State
	2352	+	Bureau of Narcotics and Dangerous Drugs Control;
	2353	+	14. “Drug” means articles:
	2354	+	a. recognized in the official United States Pharmacopeia,
	2355	+	official Homeopathic Pharmacopoeia of the United
	2356	+	States, or official National Formulary, or any
	2357	+	supplement to any of them,
	2358	+	b. intended for use in the diagnosis, cure, mitigation,
	2359	+	treatment or prevention of disease in man or other
	2360	+	animals,
	2361	+	c. other than food, intended to affect the structure or
	2362	+	any function of the body of man or other animals, and
	2363	+	d. intended for use as a component of any article
	2364	+	specified in this paragraph;
	2365	+	provided, however, the term “drug” drug does not include devices or
	2366	+	their components, parts or accessories;
	2367	+	15. “Drug-dependent person” means a person who is using a
	2368	+	controlled dangerous substance and who is in a state of psychic or
	2369	+	physical dependence, or both, arising from administration of that
	2370	+	controlled dangerous substance on a continuous basis. Drug
	2371	+	dependence is characterized by behavioral and other responses which
	2372	+	include a strong compulsion to take the substance on a continuous
	2373	+	basis in order to experience its psychic effects, or to avoid the
	2374	+	discomfort of its absence;
	2375	+
	2376	+	ENGR. S. B. NO. 475 Page 6 1
	2377	+	2
	2378	+	3
	2379	+	4
	2380	+	5
	2381	+	6
	2382	+	7
	2383	+	8
	2384	+	9
	2385	+	10
	2386	+	11
	2387	+	12
	2388	+	13
	2389	+	14
	2390	+	15
	2391	+	16
	2392	+	17
	2393	+	18
	2394	+	19
	2395	+	20
	2396	+	21
	2397	+	22
	2398	+	23
	2399	+	24
	2400	+
	2401	+	16. “Home care agency” means any sole proprietorship,
	2402	+	partnership, association, corporation, or other organization which
	2403	+	administers, offers, or provides home care services, for a fee or
	2404	+	pursuant to a contract for such services, to clients in their place
	2405	+	of residence;
	2406	+	17. “Home care services” means skilled or personal care
	2407	+	services provided to clients in their place of residence for a fee;
	2408	+	18. “Hospice” means a centrally administered, nonprofit or for-
	2409	+	profit, medically directed, nurse-coordinated program which provides
	2410	+	a continuum of home and inpatient care for the terminally ill
	2411	+	patient and the patient’s family. Such term shall also include a
	2412	+	centrally administered, nonprofit or for-profit, medically directed,
	2413	+	nurse-coordinated program if such program is licensed pursuant to
	2414	+	the provisions of the Uniform Controlled Dangerous Substances Act.
	2415	+	A hospice program offers palliative and supportive care to meet the
	2416	+	special needs arising out of the physical, emotional and spiritual
	2417	+	stresses which are experienced during the final stages of illness
	2418	+	and during dying and bereavement. This care is available twenty-
	2419	+	four (24) hours a day, seven (7) days a week, and is provided on the
	2420	+	basis of need, regardless of ability to pay. “Class A” Hospice
	2421	+	refers to Medicare-certified hospices. “Class B” refers to all
	2422	+	other providers of hospice services;
	2423	+	19. “Imitation controlled substance” means a substance that is
	2424	+	not a controlled dangerous substance, which by dosage unit
	2425	+
	2426	+	ENGR. S. B. NO. 475 Page 7 1
	2427	+	2
	2428	+	3
	2429	+	4
	2430	+	5
	2431	+	6
	2432	+	7
	2433	+	8
	2434	+	9
	2435	+	10
	2436	+	11
	2437	+	12
	2438	+	13
	2439	+	14
	2440	+	15
	2441	+	16
	2442	+	17
	2443	+	18
	2444	+	19
	2445	+	20
	2446	+	21
	2447	+	22
	2448	+	23
	2449	+	24
	2450	+
	2451	+	appearance, color, shape, size, markings or by representations made,
	2452	+	would lead a reasonable person to believe that the substance is a
	2453	+	controlled dangerous substance. In the event the appearance of the
	2454	+	dosage unit is not reasonably sufficient to establish that the
	2455	+	substance is an “imitation controlled substance” imitation
	2456	+	controlled substance, the court or authority concerned should
	2457	+	consider, in addition to all oth er factors, the following factors as
	2458	+	related to “representations made” in determining wheth er the
	2459	+	substance is an “imitation controlled substance” imitation
	2460	+	controlled substance:
	2461	+	a. statements made by an owner or by any other person in
	2462	+	control of the substance concerning the nature of the
	2463	+	substance, or its use or effect,
	2464	+	b. statements made to the recipient that the substance
	2465	+	may be resold for inordinate profit,
	2466	+	c. whether the substance is packaged in a manner normally
	2467	+	used for illicit controlled substances,
	2468	+	d. evasive tactics or actions utilized by the owner or
	2469	+	person in control of the substance to avoid detection
	2470	+	by law enforcement authorities,
	2471	+	e. prior convictions, if any, of an owner, or any other
	2472	+	person in control of the object, under state or
	2473	+	federal law related to controlled substances or fraud,
	2474	+	and
	2475	+
	2476	+	ENGR. S. B. NO. 475 Page 8 1
	2477	+	2
	2478	+	3
	2479	+	4
	2480	+	5
	2481	+	6
	2482	+	7
	2483	+	8
	2484	+	9
	2485	+	10
	2486	+	11
	2487	+	12
	2488	+	13
	2489	+	14
	2490	+	15
	2491	+	16
	2492	+	17
	2493	+	18
	2494	+	19
	2495	+	20
	2496	+	21
	2497	+	22
	2498	+	23
	2499	+	24
	2500	+
	2501	+	f. the proximity of the substances to controlled
	2502	+	dangerous substances;
	2503	+	20. “Immediate precursor” means a substance which the Director
	2504	+	has found to be and by regulation designates as being the principal
	2505	+	compound commonly used or produced primarily for use, and which is
	2506	+	an immediate chemical intermediary used, or likely to be used, in
	2507	+	the manufacture of a controlled dangerous substance, the control of
	2508	+	which is necessary to prevent, curtail or limit such manufacture;
	2509	+	21. “Laboratory” means a laboratory approved by the Director as
	2510	+	proper to be entrusted with the custody of controlled dangerous
	2511	+	substances and the use of controlled dangerous substances for
	2512	+	scientific and medical purposes and for purposes of instruction;
	2513	+	22. “Manufacture” means the production, preparation,
	2514	+	propagation, compounding or processing of a controlled dangerous
	2515	+	substance, either directly or indirectly by extraction from
	2516	+	substances of natural or synthetic origin, or independently by means
	2517	+	of chemical synthesis or by a combination of extraction and chemical
	2518	+	synthesis. “Manufacturer” includes any person who packages,
	2519	+	repackages or labels any container of any controlled dangerous
	2520	+	substance, except practitioners who dispense or compound
	2521	+	prescription orders for delivery to the ultimate consumer;
	2522	+	23. “Marijuana” means all parts of the plant Cannabis sativa
	2523	+	L., whether growing or not; the seeds thereof; the resin extracted
	2524	+	from any part of such plant; and every compound, manufacture, salt,
	2525	+
	2526	+	ENGR. S. B. NO. 475 Page 9 1
	2527	+	2
	2528	+	3
	2529	+	4
	2530	+	5
	2531	+	6
	2532	+	7
	2533	+	8
	2534	+	9
	2535	+	10
	2536	+	11
	2537	+	12
	2538	+	13
	2539	+	14
	2540	+	15
	2541	+	16
	2542	+	17
	2543	+	18
	2544	+	19
	2545	+	20
	2546	+	21
	2547	+	22
	2548	+	23
	2549	+	24
	2550	+
	2551	+	derivative, mixture or preparation of such plant, its seeds or
	2552	+	resin, but shall not include:
	2553	+	a. the mature stalks of such plant or fiber produced from
	2554	+	such stalks,
	2555	+	b. oil or cake made from the seeds of such plant,
	2556	+	including cannabidiol derived from the seeds of the
	2557	+	marijuana plant,
	2558	+	c. any other compound, manufacture, salt, derivative,
	2559	+	mixture or preparation of such mature stalks (except
	2560	+	the resin extracted therefrom), including cannabidiol
	2561	+	derived from mature stalks, fiber, oil or cake,
	2562	+	d. the sterilized seed of such plant which is incapable
	2563	+	of germination,
	2564	+	e. for any person participating in a clinical trial to
	2565	+	administer cannabidiol for the treatment of severe
	2566	+	forms of epilepsy pursuant to Section 2-802 of this
	2567	+	title, a drug or substance approved by the federal
	2568	+	Food and Drug Administration for use by those
	2569	+	participants,
	2570	+	f. for any person or the parents, legal guardians or
	2571	+	caretakers of the person who have received a written
	2572	+	certification from a physician licensed in this state
	2573	+	that the person has been diagnosed by a physician as
	2574	+	having Lennox-Gastaut syndrome, Dravet syndrome, also
	2575	+
	2576	+	ENGR. S. B. NO. 475 Page 10 1
	2577	+	2
	2578	+	3
	2579	+	4
	2580	+	5
	2581	+	6
	2582	+	7
	2583	+	8
	2584	+	9
	2585	+	10
	2586	+	11
	2587	+	12
	2588	+	13
	2589	+	14
	2590	+	15
	2591	+	16
	2592	+	17
	2593	+	18
	2594	+	19
	2595	+	20
	2596	+	21
	2597	+	22
	2598	+	23
	2599	+	24
	2600	+
	2601	+	known as severe myoclonic epilepsy of infancy, or any
	2602	+	other severe form of epilepsy that is not adequately
	2603	+	treated by traditional medical therapies, spasticity
	2604	+	due to multiple sclerosis or due to paraplegia,
	2605	+	intractable nausea and vomiting, appetite stimulation
	2606	+	with chronic wasting diseases, the substance
	2607	+	cannabidiol, a nonpsychoactive cannabinoid, found in
	2608	+	the plant Cannabis sativa L. or any other preparation
	2609	+	thereof, that has a tetrahydrocannabinol concentration
	2610	+	of not more than three-tenths of one percent (0.3%)
	2611	+	and that is delivered to the patient in the form of a
	2612	+	liquid,
	2613	+	g. any federal Food-and-Drug-Administration-approved drug
	2614	+	or substance, or
	2615	+	h. industrial hemp, from the plant Cannabis sativa L. and
	2616	+	any part of such plant, whether growing or not, with a
	2617	+	delta-9 tetrahydrocannabinol concentration of not more
	2618	+	than three-tenths of one percent (0.3%) on a dry-
	2619	+	weight basis which shall only be grown pursuant to the
	2620	+	Oklahoma Industrial Hemp Program and may be shipped
	2621	+	intrastate and interstate;
	2622	+	24. “Medical purpose” means an intention to utilize a
	2623	+	controlled dangerous substance for physical or mental treatment, for
	2624	+	diagnosis, or for the prevention of a disease condition not in
	2625	+
	2626	+	ENGR. S. B. NO. 475 Page 11 1
	2627	+	2
	2628	+	3
	2629	+	4
	2630	+	5
	2631	+	6
	2632	+	7
	2633	+	8
	2634	+	9
	2635	+	10
	2636	+	11
	2637	+	12
	2638	+	13
	2639	+	14
	2640	+	15
	2641	+	16
	2642	+	17
	2643	+	18
	2644	+	19
	2645	+	20
	2646	+	21
	2647	+	22
	2648	+	23
	2649	+	24
	2650	+
	2651	+	violation of any state or federal law and not for the purpose of
	2652	+	satisfying physiological or psychological dependence or other abuse;
	2653	+	25. “Mid-level practitioner” means an Advanced Practice
	2654	+	Registered Nurse as defined and within parameters specified in
	2655	+	Section 567.3a of Title 59 of the Oklahoma Statutes, or a certified
	2656	+	animal euthanasia technician as defined in Section 698.2 of Title 59
	2657	+	of the Oklahoma Statutes, or an animal control officer registered by
	2658	+	the Oklahoma State Bureau of Narcotics and Dangerous Drugs Control
	2659	+	under subsection B of Section 2-301 of this title within the
	2660	+	parameters of such officer’s duties under Sections 501 through 508
	2661	+	of Title 4 of the Oklahoma Statutes;
	2662	+	26. “Narcotic drug” means any of the following, whether
	2663	+	produced directly or indirectly by extraction from substances of
	2664	+	vegetable origin, or independently b y means of chemical synthesis,
	2665	+	or by a combination of extraction and chemical synthesis:
	2666	+	a. opium, coca leaves and opiates,
	2667	+	b. a compound, manufacture, salt, derivative or
	2668	+	preparation of opium, coca leaves or opiates,
	2669	+	c. cocaine, its salts, optical and geo metric isomers, and
	2670	+	salts of isomers,
	2671	+	d. ecgonine, its derivatives, their salts, isomers and
	2672	+	salts of isomers, and
	2673	+	e. a substance, and any compound, manufacture, salt,
	2674	+	derivative or preparation thereof, which is chemically
	2675	+
	2676	+	ENGR. S. B. NO. 475 Page 12 1
	2677	+	2
	2678	+	3
	2679	+	4
	2680	+	5
	2681	+	6
	2682	+	7
	2683	+	8
	2684	+	9
	2685	+	10
	2686	+	11
	2687	+	12
	2688	+	13
	2689	+	14
	2690	+	15
	2691	+	16
	2692	+	17
	2693	+	18
	2694	+	19
	2695	+	20
	2696	+	21
	2697	+	22
	2698	+	23
	2699	+	24
	2700	+
	2701	+	identical with any of the substan ces referred to in
	2702	+	subparagraphs a through d of this paragraph, except
	2703	+	that the words “narcotic drug” narcotic drug as used
	2704	+	in Section 2-101 et seq. of this title shall not
	2705	+	include decocainized coca leaves or extracts of coca
	2706	+	leaves, which extracts do not contain cocain e or
	2707	+	ecgonine;
	2708	+	27. “Opiate” or “opioid” means any Schedule II, III, IV or V
	2709	+	substance having an addiction-forming or addiction-sustaining
	2710	+	liability similar to morphine or being capable of conversion into a
	2711	+	drug having such addiction-forming or addiction -sustaining
	2712	+	liability. The terms do not include, unless specifically designated
	2713	+	as controlled under the Uniform Controlled Dangerous Substances Act,
	2714	+	the dextrorotatory isomer of 3-methoxy-n-methyl-morphinan and its
	2715	+	salts (dextromethorphan). The terms do include the racemic and
	2716	+	levorotatory forms;
	2717	+	28. “Opium poppy” means the plant of the species Papaver
	2718	+	somniferum L., except the seeds thereof;
	2719	+	29. “Peace officer” means a police officer, sheriff, deputy
	2720	+	sheriff, district attorney’s investigator, investigato r from the
	2721	+	Office of the Attorney General, or any other person elected or
	2722	+	appointed by law to enforce any of the criminal laws of this state
	2723	+	or of the United States;
	2724	+
	2725	+	ENGR. S. B. NO. 475 Page 13 1
	2726	+	2
	2727	+	3
	2728	+	4
	2729	+	5
	2730	+	6
	2731	+	7
	2732	+	8
	2733	+	9
	2734	+	10
	2735	+	11
	2736	+	12
	2737	+	13
	2738	+	14
	2739	+	15
	2740	+	16
	2741	+	17
	2742	+	18
	2743	+	19
	2744	+	20
	2745	+	21
	2746	+	22
	2747	+	23
	2748	+	24
	2749	+
	2750	+	30. “Person” means an individual, corporation, government or
	2751	+	governmental subdivision or agency, business trust, estate, trust,
	2752	+	partnership or association, or any other legal entity;
	2753	+	31. “Poppy straw” means all parts, except the seeds, of the
	2754	+	opium poppy, after mowing;
	2755	+	32. “Practitioner” means:
	2756	+	a. (1) a medical doctor or osteopathic physicia n,
	2757	+	(2) a dentist,
	2758	+	(3) a podiatrist,
	2759	+	(4) an optometrist,
	2760	+	(5) a veterinarian,
	2761	+	(6) a physician assistant or Advanced Practice
	2762	+	Registered Nurse under the supervision of a
	2763	+	licensed medical doctor or osteopathic physician,
	2764	+	(7) a scientific investigator, or
	2765	+	(8) any other person,
	2766	+	licensed, registered or otherwise permitted to
	2767	+	prescribe, distribute, dispense, conduct research with
	2768	+	respect to, use for scientific purposes or administer
	2769	+	a controlled dangerous substance in the course of
	2770	+	professional practice or research in this state, or
	2771	+	b. a pharmacy, hospital, laboratory or other institution
	2772	+	licensed, registered or otherwise permitted to
	2773	+	distribute, dispense, conduct research with respect
	2774	+
	2775	+	ENGR. S. B. NO. 475 Page 14 1
	2776	+	2
	2777	+	3
	2778	+	4
	2779	+	5
	2780	+	6
	2781	+	7
	2782	+	8
	2783	+	9
	2784	+	10
	2785	+	11
	2786	+	12
	2787	+	13
	2788	+	14
	2789	+	15
	2790	+	16
	2791	+	17
	2792	+	18
	2793	+	19
	2794	+	20
	2795	+	21
	2796	+	22
	2797	+	23
	2798	+	24
	2799	+
	2800	+	to, use for scientific purposes or administer a
	2801	+	controlled dangerous substance in the course of
	2802	+	professional practice or research in this state;
	2803	+	33. “Production” includes the manufacture, planting,
	2804	+	cultivation, growing or harvesting of a controlled dangerous
	2805	+	substance;
	2806	+	34. “State” means the State of Oklahoma or any other state of
	2807	+	the United States;
	2808	+	35. “Ultimate user” means a person who lawfully possesses a
	2809	+	controlled dangerous substance for the person’s own use or for the
	2810	+	use of a member of the person’s household or for administration to
	2811	+	an animal owned by the person or by a member of the person’s
	2812	+	household;
	2813	+	36. “Drug paraphernalia” means all equipment, products and
	2814	+	materials of any kind which are used, intended for use, or fashioned
	2815	+	specifically for use in planting, propagating, cultivating, growing,
	2816	+	harvesting, manufacturing, comp ounding, converting, producing,
	2817	+	processing, preparing, testing, analyzing, packaging, repackaging,
	2818	+	storing, containing, concealing, injecting, ingesting, inhaling or
	2819	+	otherwise introducing into the human body, a controlled dangerous
	2820	+	substance in violation o f the Uniform Controlled Dangerous
	2821	+	Substances Act including, but not limited to:
	2822	+	a. kits used, intended for use, or fashioned specifically
	2823	+	for use in planting, propagating, cultivating, growing
	2824	+
	2825	+	ENGR. S. B. NO. 475 Page 15 1
	2826	+	2
	2827	+	3
	2828	+	4
	2829	+	5
	2830	+	6
	2831	+	7
	2832	+	8
	2833	+	9
	2834	+	10
	2835	+	11
	2836	+	12
	2837	+	13
	2838	+	14
	2839	+	15
	2840	+	16
	2841	+	17
	2842	+	18
	2843	+	19
	2844	+	20
	2845	+	21
	2846	+	22
	2847	+	23
	2848	+	24
	2849	+
	2850	+	or harvesting of any species of plant which is a
	2851	+	controlled dangerous substance or from which a
	2852	+	controlled dangerous substance can be derived,
	2853	+	b. kits used, intended for use, or fashioned specifically
	2854	+	for use in manufacturing, compounding, converting,
	2855	+	producing, processing or preparing controlled
	2856	+	dangerous substances ,
	2857	+	c. isomerization devices used, intended for use, or
	2858	+	fashioned specifically for use in increasing the
	2859	+	potency of any species of plant which is a controlled
	2860	+	dangerous substance,
	2861	+	d. testing equipment used, intended for use, or fashioned
	2862	+	specifically for use in identifying, or in analyzing
	2863	+	the strength, effectiveness or purity of controlled
	2864	+	dangerous substances,
	2865	+	e. scales and balances used, intended for use, or
	2866	+	fashioned specifically for use in weighing or
	2867	+	measuring controlled dangerous substances,
	2868	+	f. diluents and adulterants, such as quinine
	2869	+	hydrochloride, mannitol, mannite, dextrose and
	2870	+	lactose, used, intended for use, or fashioned
	2871	+	specifically for use in cutting controlled dangerous
	2872	+	substances,
	2873	+
	2874	+	ENGR. S. B. NO. 475 Page 16 1
	2875	+	2
	2876	+	3
	2877	+	4
	2878	+	5
	2879	+	6
	2880	+	7
	2881	+	8
	2882	+	9
	2883	+	10
	2884	+	11
	2885	+	12
	2886	+	13
	2887	+	14
	2888	+	15
	2889	+	16
	2890	+	17
	2891	+	18
	2892	+	19
	2893	+	20
	2894	+	21
	2895	+	22
	2896	+	23
	2897	+	24
	2898	+
	2899	+	g. separation gins and sifters used, intended for use, or
	2900	+	fashioned specifically for use in removing twigs and
	2901	+	seeds from, or in otherwise cleaning or refining,
	2902	+	marijuana,
	2903	+	h. blenders, bowls, containers, spoons and mixing devices
	2904	+	used, intended for use, or fashioned specifically for
	2905	+	use in compounding controlled dange rous substances,
	2906	+	i. capsules, balloons, envelopes and other containers
	2907	+	used, intended for use, or fashioned specifically for
	2908	+	use in packaging small quantities of controlled
	2909	+	dangerous substances,
	2910	+	j. containers and other objects used, intended for use,
	2911	+	or fashioned specifically for use in parenterally
	2912	+	injecting controlled dangerous substances into the
	2913	+	human body,
	2914	+	k. hypodermic syringes, needles and other objects used,
	2915	+	intended for use, or fashioned specifically for use in
	2916	+	parenterally injecting controlled dan gerous substances
	2917	+	into the human body,
	2918	+	l. objects used, intended for use, or fashioned
	2919	+	specifically for use in ingesting, inhaling or
	2920	+	otherwise introducing marijuana, cocaine, hashish or
	2921	+	hashish oil into the human body, such as:
	2922	+
	2923	+	ENGR. S. B. NO. 475 Page 17 1
	2924	+	2
	2925	+	3
	2926	+	4
	2927	+	5
	2928	+	6
	2929	+	7
	2930	+	8
	2931	+	9
	2932	+	10
	2933	+	11
	2934	+	12
	2935	+	13
	2936	+	14
	2937	+	15
	2938	+	16
	2939	+	17
	2940	+	18
	2941	+	19
	2942	+	20
	2943	+	21
	2944	+	22
	2945	+	23
	2946	+	24
	2947	+
	2948	+	(1) metal, wooden, acrylic, glass, stone, plastic or
	2949	+	ceramic pipes with or without screens, permanent
	2950	+	screens, hashish heads or punctured metal bowls,
	2951	+	(2) water pipes,
	2952	+	(3) carburetion tubes and devices,
	2953	+	(4) smoking and carburetion masks,
	2954	+	(5) roach clips, meaning objects used to hold burning
	2955	+	material, such as a marijuana cigarette, that has
	2956	+	become too small or too short to be held in the
	2957	+	hand,
	2958	+	(6) miniature cocaine spoons and cocaine vials,
	2959	+	(7) chamber pipes,
	2960	+	(8) carburetor pipes,
	2961	+	(9) electric pipes,
	2962	+	(10) air-driven pipes,
	2963	+	(11) chillums,
	2964	+	(12) bongs, or
	2965	+	(13) ice pipes or chillers,
	2966	+	m. all hidden or novelty pipes, and
	2967	+	n. any pipe that has a tobacco bowl or chamber of less
	2968	+	than one-half (1/2) inch in diameter in which there is
	2969	+	any detectable residue of any controlled dangerous
	2970	+	substance as defined in this section or any other
	2971	+	substances not legal for possession or use;
	2972	+
	2973	+	ENGR. S. B. NO. 475 Page 18 1
	2974	+	2
	2975	+	3
	2976	+	4
	2977	+	5
	2978	+	6
	2979	+	7
	2980	+	8
	2981	+	9
	2982	+	10
	2983	+	11
	2984	+	12
	2985	+	13
	2986	+	14
	2987	+	15
	2988	+	16
	2989	+	17
	2990	+	18
	2991	+	19
	2992	+	20
	2993	+	21
	2994	+	22
	2995	+	23
	2996	+	24
	2997	+
	2998	+	provided, however, the term “drug paraphernalia” drug paraphernalia
	2999	+	shall not include separation gins intended for use in preparing tea
	3000	+	or spice, clamps used for constructing electrical equipme nt, water
	3001	+	pipes designed for ornamentation in which no detectable amount of an
	3002	+	illegal substance is found or pipes designed and used solely for
	3003	+	smoking tobacco, traditional pipes of an American Indian tribal
	3004	+	religious ceremony, or antique pipes that are th irty (30) years of
	3005	+	age or older;
	3006	+	37. a. “Synthetic controlled substance” means a substance:
	3007	+	(1) the chemical structure of which is substantially
	3008	+	similar to the chemical structure of a controlled
	3009	+	dangerous substance in Schedule I or II,
	3010	+	(2) which has a stimulant, depressant, or
	3011	+	hallucinogenic effect on the cent ral nervous
	3012	+	system that is substantially similar to or
	3013	+	greater than the stimulant, depressant or
	3014	+	hallucinogenic effect on the central nervous
	3015	+	system of a controlled dangerous substance in
	3016	+	Schedule I or II, or
	3017	+	(3) with respect to a particular person, which such
	3018	+	person represents or intends to have a stimulant,
	3019	+	depressant, or hallucinogenic effect on the
	3020	+	central nervous system that is substantially
	3021	+	similar to or greater than the stimulant,
	3022	+
	3023	+	ENGR. S. B. NO. 475 Page 19 1
	3024	+	2
	3025	+	3
	3026	+	4
	3027	+	5
	3028	+	6
	3029	+	7
	3030	+	8
	3031	+	9
	3032	+	10
	3033	+	11
	3034	+	12
	3035	+	13
	3036	+	14
	3037	+	15
	3038	+	16
	3039	+	17
	3040	+	18
	3041	+	19
	3042	+	20
	3043	+	21
	3044	+	22
	3045	+	23
	3046	+	24
	3047	+
	3048	+	depressant, or hallucinogenic effect on the
	3049	+	central nervous system of a controlled dangerous
	3050	+	substance in Schedule I or II.
	3051	+	b. The designation of gamma butyrolactone or any other
	3052	+	chemical as a precursor, pursuant to Section 2-322 of
	3053	+	this title, does not preclude a findin g pursuant to
	3054	+	subparagraph a of this paragraph that the chemical is
	3055	+	a synthetic controlled substance.
	3056	+	c. “Synthetic controlled substance” does not include:
	3057	+	(1) a controlled dangerous substance,
	3058	+	(2) any substance for which there is an approved new
	3059	+	drug application,
	3060	+	(3) with respect to a particular person any
	3061	+	substance, if an exemption is in effect for
	3062	+	investigational use, for that person under the
	3063	+	provisions of Section 505 of the Federal Food,
	3064	+	Drug and Cosmetic Act, Title 21 of the United
	3065	+	States Code, Section 355, to the extent conduct
	3066	+	with respect to such subst ance is pursuant to
	3067	+	such exemption, or
	3068	+	(4) any substance to the extent not intended for
	3069	+	human consumption before such an exemption takes
	3070	+	effect with respect to that substance.
	3071	+
	3072	+	ENGR. S. B. NO. 475 Page 20 1
	3073	+	2
	3074	+	3
	3075	+	4
	3076	+	5
	3077	+	6
	3078	+	7
	3079	+	8
	3080	+	9
	3081	+	10
	3082	+	11
	3083	+	12
	3084	+	13
	3085	+	14
	3086	+	15
	3087	+	16
	3088	+	17
	3089	+	18
	3090	+	19
	3091	+	20
	3092	+	21
	3093	+	22
	3094	+	23
	3095	+	24
	3096	+
	3097	+	d. Prima facie evidence that a substance containing
	3098	+	salvia divinorum has been en hanced, concentrated or
	3099	+	chemically or physically altered shall give rise to a
	3100	+	rebuttable presumption that the substance is a
	3101	+	synthetic controlled substance;
	3102	+	38. “Tetrahydrocannabinols” means all substances that have been
	3103	+	chemically synthesized to emulate the tetrahydrocannabinols of
	3104	+	marijuana, specifically including any tetrahydrocannabinols derived
	3105	+	from industrial hemp;
	3106	+	39. “Isomer” means the optical isomer, except as used in
	3107	+	subsections C and F o f Section 2-204 of this title and paragraph 4
	3108	+	of subsection A of Section 2-206 of this title. As used in
	3109	+	subsections C and F of Section 2-204 of this title, “isomer” isomer
	3110	+	means the optical, positional or geometric isomer. As used in
	3111	+	paragraph 4 of subsection A of Section 2-206 of this title, the term
	3112	+	“isomer” isomer means the optical or geometric isomer;
	3113	+	40. “Hazardous materials” means materials, whether solid,
	3114	+	liquid or gas, which are toxic to human, animal, aquatic or plant
	3115	+	life, and the disposal of which materia ls is controlled by state or
	3116	+	federal guidelines;
	3117	+	41. “Anhydrous ammonia” means any substance that exhibits
	3118	+	cryogenic evaporative behavior and tests positive for ammonia;
	3119	+	42. “Acute pain” means pain, whether resulting from disease,
	3120	+	accidental or intentional trauma or other cause, that the
	3121	+
	3122	+	ENGR. S. B. NO. 475 Page 21 1
	3123	+	2
	3124	+	3
	3125	+	4
	3126	+	5
	3127	+	6
	3128	+	7
	3129	+	8
	3130	+	9
	3131	+	10
	3132	+	11
	3133	+	12
	3134	+	13
	3135	+	14
	3136	+	15
	3137	+	16
	3138	+	17
	3139	+	18
	3140	+	19
	3141	+	20
	3142	+	21
	3143	+	22
	3144	+	23
	3145	+	24
	3146	+
	3147	+	practitioner reasonably expects to last only a short period of time.
	3148	+	“Acute pain” Acute pain does not include chronic pain, pain being
	3149	+	treated as part of cancer care, hospice or other end-of-life care,
	3150	+	or pain being treated as part of palliative care;
	3151	+	43. “Chronic pain” means pain that persists beyond the usual
	3152	+	course of an acute disease or healing of an injury. “Chronic pain”
	3153	+	Chronic pain may or may not be associated with an acute or chronic
	3154	+	pathologic process that causes continuous or intermittent pain over
	3155	+	months or years;
	3156	+	44. “Initial prescription” means a prescription issued to a
	3157	+	patient who:
	3158	+	a. has never previously been issued a prescription for
	3159	+	the drug or its pharmaceutical equivalent in the past
	3160	+	year, or
	3161	+	b. requires a prescription for the drug or its
	3162	+	pharmaceutical equivalent due to a surgica l procedure
	3163	+	or new acute event and has previously had a
	3164	+	prescription for the drug or its pharmaceutical
	3165	+	equivalent within the past year.
	3166	+	When determining whether a patient was previously issued a
	3167	+	prescription for a drug or its pharmaceutical equivalent, th e
	3168	+	practitioner shall consult with the patient and review the medical
	3169	+	record and prescription monitoring information of the patient;
	3170	+
	3171	+	ENGR. S. B. NO. 475 Page 22 1
	3172	+	2
	3173	+	3
	3174	+	4
	3175	+	5
	3176	+	6
	3177	+	7
	3178	+	8
	3179	+	9
	3180	+	10
	3181	+	11
	3182	+	12
	3183	+	13
	3184	+	14
	3185	+	15
	3186	+	16
	3187	+	17
	3188	+	18
	3189	+	19
	3190	+	20
	3191	+	21
	3192	+	22
	3193	+	23
	3194	+	24
	3195	+
	3196	+	45. “Patient-provider agreement” means a written contract or
	3197	+	agreement that is executed between a practitioner and a patien t,
	3198	+	prior to the commencement of treatment for chronic pain using an
	3199	+	opioid drug as a means to:
	3200	+	a. explain the possible risk of development of physical
	3201	+	or psychological dependence in the patient and prevent
	3202	+	the possible development of addiction,
	3203	+	b. document the understanding of both the practitioner
	3204	+	and the patient regarding the patient-provider
	3205	+	agreement of the patient,
	3206	+	c. establish the rights of the patient in association
	3207	+	with treatment and the obligations of the patient in
	3208	+	relation to the responsible use, discontinuation of
	3209	+	use, and storage of opioid drugs, including any
	3210	+	restrictions on the refill of prescriptions or the
	3211	+	acceptance of opioid prescriptions from practitioners,
	3212	+	d. identify the specific medications and other modes of
	3213	+	treatment, including physical therapy or exercise,
	3214	+	relaxation or psychological counseling, that are
	3215	+	included as a part of the patient-provider agreement,
	3216	+	e. specify the measures the practitioner may employ to
	3217	+	monitor the compliance of the patient including, but
	3218	+	not limited to, rand om specimen screens and pill
	3219	+	counts, and
	3220	+
	3221	+	ENGR. S. B. NO. 475 Page 23 1
	3222	+	2
	3223	+	3
	3224	+	4
	3225	+	5
	3226	+	6
	3227	+	7
	3228	+	8
	3229	+	9
	3230	+	10
	3231	+	11
	3232	+	12
	3233	+	13
	3234	+	14
	3235	+	15
	3236	+	16
	3237	+	17
	3238	+	18
	3239	+	19
	3240	+	20
	3241	+	21
	3242	+	22
	3243	+	23
	3244	+	24
	3245	+
	3246	+	f. delineate the process for terminating the agreement,
	3247	+	including the consequences if the practitioner has
	3248	+	reason to believe that the patient is not complying
	3249	+	with the terms of the agreement. Compliance with the
	3250	+	“consent items” shall constitute a valid, informed
	3251	+	consent for opioid therapy. The practitioner shall be
	3252	+	held harmless from civil litigation for failure to
	3253	+	treat pain if the event occurs because of nonadherence
	3254	+	by the patient with any of the provisions of the
	3255	+	patient-provider agreement;
	3256	+	46. “Serious illness” means a medical illness or physical
	3257	+	injury or condition that substantially affects quality of life for
	3258	+	more than a short period of time. “Serious illness” Serious illness
	3259	+	includes, but is not limited to, Alzheimer’s disease or related
	3260	+	dementias, lung disease, cancer, heart failure, renal failure, liver
	3261	+	failure or chronic, unremitting or intractable pain such as
	3262	+	neuropathic pain; and
	3263	+	47. “Straw person or party” means a third party who is put up
	3264	+	in name only to take part in a transaction. This term includes but
	3265	+	is not limited to a n ominal party to a transaction, one who acts as
	3266	+	an agent for another for the purpose of taking tit le to property and
	3267	+	executing whatever documents and instruments the principal may
	3268	+	direct respecting the property, or a person who purchases property
	3269	+
	3270	+	ENGR. S. B. NO. 475 Page 24 1
	3271	+	2
	3272	+	3
	3273	+	4
	3274	+	5
	3275	+	6
	3276	+	7
	3277	+	8
	3278	+	9
	3279	+	10
	3280	+	11
	3281	+	12
	3282	+	13
	3283	+	14
	3284	+	15
	3285	+	16
	3286	+	17
	3287	+	18
	3288	+	19
	3289	+	20
	3290	+	21
	3291	+	22
	3292	+	23
	3293	+	24
	3294	+
	3295	+	for another to conceal the identity of the real purchaser or to
	3296	+	accomplish some purpose otherwise not allowed; and
	3297	+	47. 48. “Surgical procedure” means a procedure that is
	3298	+	performed for the purpose of structurally altering the human body by
	3299	+	incision or destruction of tissues as part of the practice of
	3300	+	medicine. This term includes the diagnostic or therapeutic
	3301	+	treatment of conditions or disease processes by use of instruments
	3302	+	such as lasers, ultrasound, ionizing, radiation, scalpels, probes or
	3303	+	needles that cause localized alteration or transportation of live
	3304	+	human tissue by cutting, burning, vaporizing, freezing, suturing,
	3305	+	probing or manipulating by closed reduction for major dislocations
	3306	+	or fractures, or otherwise altering by any mechanical, thermal,
	3307	+	light-based, electromagnetic or chemical means.
	3308	+	SECTION 10. AMENDATORY 63 O.S. 2021, Section 2-110, is
	3309	+	amended to read as follows:
	3310	+	Section 2-110. The Director of the Oklahoma State Bureau of
	3311	+	Narcotics and Dangerous Drugs Control may empl oy attorneys, who
	3312	+	shall be unclassified employees of the state, or contract with
	3313	+	attorneys, as needed. These at torneys may advise the Director, the
	3314	+	Oklahoma State Bureau of Narcotics and Dangerous Drugs Control
	3315	+	Commission and Bureau personnel on all legal matters and shall
	3316	+	appear for and represent the Director, the Commission and Bureau
	3317	+	personnel in all administrat ive hearings and all litigation or other
	3318	+	proceedings which may arise in the discharge of their duties. At
	3319	+
	3320	+	ENGR. S. B. NO. 475 Page 25 1
	3321	+	2
	3322	+	3
	3323	+	4
	3324	+	5
	3325	+	6
	3326	+	7
	3327	+	8
	3328	+	9
	3329	+	10
	3330	+	11
	3331	+	12
	3332	+	13
	3333	+	14
	3334	+	15
	3335	+	16
	3336	+	17
	3337	+	18
	3338	+	19
	3339	+	20
	3340	+	21
	3341	+	22
	3342	+	23
	3343	+	24
	3344	+
	3345	+	the request of the Oklahoma State Bur eau of Narcotics and Danger ous
	3346	+	Drugs Control Commission, such attorney shall assist the district
	3347	+	attorney or the Attorney General in prosecuting charges of violators
	3348	+	of the Uniform Controlled Dangerous Substances Act or any felony
	3349	+	relating to or arising fr om a violation of the Unifo rm Controlled
	3350	+	Dangerous Substances Act. Attorneys for the Bureau who have been
	3351	+	certified by the Council on Law Enforcement Education and Training
	3352	+	to carry a weapon or have been issued a handgun license pursuant to
	3353	+	the provisions of the Oklahoma Self -Defense Act shall be allowed to
	3354	+	carry weapons pursuant to paragraph 3 of subsection A of S ection
	3355	+	1272 of Title 21 of the Oklahoma Statutes. Th ese attorneys,
	3356	+	pursuant to this provision, shall not be considered eligible to
	3357	+	participate in the Oklahoma Law Enforce ment Retirement System. If a
	3358	+	conflict of interest would be created by such attorney representing
	3359	+	the Director, the Commission or Bureau p ersonnel, additional counsel
	3360	+	may be hired upon approval of the Oklahoma State Bureau of Nar cotics
	3361	+	and Dangerous Drugs Control Commission.
	3362	+	SECTION 11. AMENDATORY 63 O.S. 20 21, Section 2-304, is
	3363	+	amended to read as follows:
	3364	+	Section 2-304. A. A registration, pursuant to Section 2-303 of
	3365	+	this title, to manufacture, distribute, dispense, prescribe,
	3366	+	administer or use for scientific purposes a controlled dan gerous
	3367	+	substance shall be lim ited, conditioned, denied, suspended,
	3368	+	annulled, or revoked by the Director of the Oklahoma State Bureau of
	3369	+
	3370	+	ENGR. S. B. NO. 475 Page 26 1
	3371	+	2
	3372	+	3
	3373	+	4
	3374	+	5
	3375	+	6
	3376	+	7
	3377	+	8
	3378	+	9
	3379	+	10
	3380	+	11
	3381	+	12
	3382	+	13
	3383	+	14
	3384	+	15
	3385	+	16
	3386	+	17
	3387	+	18
	3388	+	19
	3389	+	20
	3390	+	21
	3391	+	22
	3392	+	23
	3393	+	24
	3394	+
	3395	+	Narcotics and Dangerous Dr ugs Control upon a finding that the
	3396	+	registrant:
	3397	+	1. Has materially falsified any application filed pursuant to
	3398	+	the Uniform Controlled Dangerous Substances Act or required by t he
	3399	+	Uniform Controlled Dangerous Substanc es Act. It shall be unlawful
	3400	+	to knowingly and willfully:
	3401	+	a. make false statements, include false data or omit
	3402	+	material information on an application for a
	3403	+	registration with the Oklahoma State Bureau of
	3404	+	Narcotics and Dangerous Drugs Control, or
	3405	+	b. provide false data or omit material information in any
	3406	+	records or reports required by rule or law to be
	3407	+	created, maintained or submitted to the Bureau .
	3408	+	Any registrant or applicant for a registration or any official,
	3409	+	agent or employee of any registrant or applicant for a registration
	3410	+	who violates the provisions of this paragraph shall be guilty of a
	3411	+	misdemeanor and additionally subject to administrative action ;
	3412	+	2. Has been found guilty of, entered a plea of guilty or
	3413	+	entered a plea of nolo contendere to a misdemean or relating to any
	3414	+	substance defined herein as a controlled dangerous substance or any
	3415	+	felony under the laws of any state or the United States;
	3416	+	3. Has had his or her federal registration retired, suspended
	3417	+	or revoked by a competent federal authority and i s no longer
	3418	+	authorized by federal la w to manufacture, distribute, dispense,
	3419	+
	3420	+	ENGR. S. B. NO. 475 Page 27 1
	3421	+	2
	3422	+	3
	3423	+	4
	3424	+	5
	3425	+	6
	3426	+	7
	3427	+	8
	3428	+	9
	3429	+	10
	3430	+	11
	3431	+	12
	3432	+	13
	3433	+	14
	3434	+	15
	3435	+	16
	3436	+	17
	3437	+	18
	3438	+	19
	3439	+	20
	3440	+	21
	3441	+	22
	3442	+	23
	3443	+	24
	3444	+
	3445	+	prescribe, administer or use for scientific purposes controlled
	3446	+	dangerous substances;
	3447	+	4. Has failed to maintain effective controls against the
	3448	+	diversion of controlled dangerous su bstances to unauthorized persons
	3449	+	or entities;
	3450	+	5. Has prescribed, dispensed or administered a controlled
	3451	+	dangerous substance from schedules other than those specifi ed in his
	3452	+	or her state or federal registration;
	3453	+	6. Has had a restriction, suspension, revoc ation, limitation,
	3454	+	condition or probation placed on his or her professional license or
	3455	+	certificate or practice as a result of a proceeding pursuant to the
	3456	+	general statutes;
	3457	+	7. Is abusing or, within the past five (5) years, has abused or
	3458	+	excessively used drugs or controlled dangerous sub stances;
	3459	+	8. Has prescribed, sold, administered or ordered any controlled
	3460	+	substance for an immediate family member, himself or herse lf;
	3461	+	provided that this shall not apply to a medical emergency when no
	3462	+	other doctor is availa ble to respond to the emergency ;
	3463	+	9. Has possessed, used, prescribed, dispensed or administered
	3464	+	drugs or controlled dangerous substances for other than legitimate
	3465	+	medical or scientific purposes or for purposes outsid e the normal
	3466	+	course of his or her profes sional practice;
	3467	+	10. Has been under the influence of alcohol or another
	3468	+	intoxicating substance which adversely affected the central nervous
	3469	+
	3470	+	ENGR. S. B. NO. 475 Page 28 1
	3471	+	2
	3472	+	3
	3473	+	4
	3474	+	5
	3475	+	6
	3476	+	7
	3477	+	8
	3478	+	9
	3479	+	10
	3480	+	11
	3481	+	12
	3482	+	13
	3483	+	14
	3484	+	15
	3485	+	16
	3486	+	17
	3487	+	18
	3488	+	19
	3489	+	20
	3490	+	21
	3491	+	22
	3492	+	23
	3493	+	24
	3494	+
	3495	+	system, vision, hearing or other sensory or motor functioning to
	3496	+	such degree the person was impaired during the per formance of his or
	3497	+	her job; or
	3498	+	11. Has violated any federal law relating to any controlled
	3499	+	substances, any provision of the Uniform Controlled Dangerous
	3500	+	Substances Act or any rules of the Oklahoma State Bureau of
	3501	+	Narcotics and Dangerous Drugs Control.
	3502	+	B. In the event the Director suspends or revokes a registration
	3503	+	granted under Section 2-303 of this title, all controlled dangerous
	3504	+	substances owned or possessed by t he registrant pursuant to such
	3505	+	registration at the t ime of denial revocation or suspension or the
	3506	+	effective date of the revocation order, as the case may be, may in
	3507	+	the discretion of the Director be impounded and preserved . All
	3508	+	controlled dangerous substa nces not impounded or preserved by the
	3509	+	Director shall be maintained by the registrant . No disposition,
	3510	+	purchase, distribution , sale, or transfer may be made of substances
	3511	+	impounded and preserved until the time for taking an appeal has
	3512	+	elapsed or until all appeals have been concluded unless a court,
	3513	+	upon application therefor, orders the sale of p erishable substances
	3514	+	and the deposit of the proceeds of the sale with the court. Upon a
	3515	+	revocation order becoming final, all such co ntrolled dangerous
	3516	+	substances shall be forfeited to the state or otherwise considered
	3517	+	waste and submitted to a licensed was te disposal service for
	3518	+	destruction pursuant to Section 430 of this title.
	3519	+
	3520	+	ENGR. S. B. NO. 475 Page 29 1
	3521	+	2
	3522	+	3
	3523	+	4
	3524	+	5
	3525	+	6
	3526	+	7
	3527	+	8
	3528	+	9
	3529	+	10
	3530	+	11
	3531	+	12
	3532	+	13
	3533	+	14
	3534	+	15
	3535	+	16
	3536	+	17
	3537	+	18
	3538	+	19
	3539	+	20
	3540	+	21
	3541	+	22
	3542	+	23
	3543	+	24
	3544	+
	3545	+	C. The Drug Enforcement Administration shall promptly be
	3546	+	notified of all orders suspendi ng or revoking registration and all
	3547	+	forfeitures of controlled dangerous substances.
	3548	+	D. In lieu of or in addition to any other remed ies available to
	3549	+	the Director, if a finding is made that a registrant has committed
	3550	+	any act in violation of federal law rela ting to any controlled
	3551	+	substance, any provision of the Uniform Controlled Dangerous
	3552	+	Substances Act or any rules of the Oklahoma Stat e Bureau of
	3553	+	Narcotics and Dangerous Drugs Control, the Director is hereby
	3554	+	authorized to assess an administrative penalty not to exceed Two
	3555	+	Thousand Dollars ($2,000.00) for each such act . The provisions of
	3556	+	this subsection shall not apply to violations of s ubsection G of
	3557	+	Section 2-309D of this title. Nothing in this section shall be
	3558	+	construed so as to permit the Director of the State Bureau of
	3559	+	Narcotics and Dangerous Drugs Control to assess administrative fines
	3560	+	for violations of the provisions of subsection G of Section 2-309D
	3561	+	of this title.
	3562	+	SECTION 12. AMENDATORY 63 O.S. 2021, Section 2-305, is
	3563	+	amended to read as follows:
	3564	+	Section 2-305. A. Before denying, suspending or revoking a
	3565	+	registration, refusing a renewal of registration or taking
	3566	+	administrative action on a n onregistrant engaged in manufacturing,
	3567	+	distributing, dispensing, prescribing, administer ing or using for
	3568	+	scientific purposes any controlled dange rous substance within or
	3569	+
	3570	+	ENGR. S. B. NO. 475 Page 30 1
	3571	+	2
	3572	+	3
	3573	+	4
	3574	+	5
	3575	+	6
	3576	+	7
	3577	+	8
	3578	+	9
	3579	+	10
	3580	+	11
	3581	+	12
	3582	+	13
	3583	+	14
	3584	+	15
	3585	+	16
	3586	+	17
	3587	+	18
	3588	+	19
	3589	+	20
	3590	+	21
	3591	+	22
	3592	+	23
	3593	+	24
	3594	+
	3595	+	into this state, the Director shall serve upon the applicant or
	3596	+	registrant an order to show cause why registration should not be
	3597	+	denied, revoked or suspended or why the renewal should not be
	3598	+	refused. The order to show ca use shall contain a statement of the
	3599	+	basis therefor and shall call upon the applicant or registrant to
	3600	+	appear before the appropriate person or agency at a time and place
	3601	+	within thirty (30) days after the date of service of the order, but
	3602	+	in the case of a denial or renewal of registration the sho w cause
	3603	+	order shall be served within thirty ( 30) days before the expiration
	3604	+	of the registration. These proceedings shall be conducted in
	3605	+	accordance with the Administrative Procedures Act without regard to
	3606	+	any criminal prosecution or other proceeding . Proceedings to refuse
	3607	+	renewal of registration sh all not abate the existing registr ation
	3608	+	which shall remain in effect pending the outcome of the
	3609	+	administrative hearing In addition to any other remedies provided
	3610	+	for by law, the Director shall issue a written order to be served on
	3611	+	the parties before annull ing, conditioning, suspending or revoking
	3612	+	any registration that the Director has reason to believe is
	3613	+	operating inconsistent with any provision of Section 2-303 of this
	3614	+	title, pursuant to Section 2 -304 of this title or otherwise where
	3615	+	there has been a violation of any federal law , any rule or
	3616	+	regulation of the Drug Enforcement Administration, any provision of
	3617	+	the Uniform Controlled Dangerous Substances Act, or any rules or
	3618	+
	3619	+	ENGR. S. B. NO. 475 Page 31 1
	3620	+	2
	3621	+	3
	3622	+	4
	3623	+	5
	3624	+	6
	3625	+	7
	3626	+	8
	3627	+	9
	3628	+	10
	3629	+	11
	3630	+	12
	3631	+	13
	3632	+	14
	3633	+	15
	3634	+	16
	3635	+	17
	3636	+	18
	3637	+	19
	3638	+	20
	3639	+	21
	3640	+	22
	3641	+	23
	3642	+	24
	3643	+
	3644	+	regulations of the Oklahoma State Bureau of N arcotics and Dangerous
	3645	+	Drugs Control.
	3646	+	B. The Director shall suspend , without an order to show cause,
	3647	+	any registration simultaneously with the institution of proceedings
	3648	+	under Section 2-304 of this title, if h e or she finds there is
	3649	+	imminent danger to the public health or safety which warrants this
	3650	+	action. The suspension shall continue in effect until the
	3651	+	conclusion of the proceedings, including judicial revie w thereof,
	3652	+	unless sooner withdrawn by the Director or dissolved by a court of
	3653	+	competent jurisdicti on The written order shall state with
	3654	+	specificity the nature of the violation or basis for the action.
	3655	+	The Director may impose any disciplinary action authoriz ed by the
	3656	+	Uniform Controlled Dangerous Substances Act or rules of the Oklahoma
	3657	+	State Bureau of Narcotics and Dangerous Drugs Control including, but
	3658	+	not limited to, the assessment of monetary penalties.
	3659	+	C. Any written order issued pursuant to the provisions of this
	3660	+	section shall become a final order unless the registrant requests an
	3661	+	administrative hearing in accordance with the rules and regulations
	3662	+	promulgated by the Director within thirty (30) days of issuance.
	3663	+	Upon such request, the Director shall promptly initiate
	3664	+	administrative proceedings and serve formal notice of the
	3665	+	proceedings pursuant to S ection 309 of Title 75 of the Oklahoma
	3666	+	Statutes. Nothing in this section shall be construed so as to
	3667	+
	3668	+	ENGR. S. B. NO. 475 Page 32 1
	3669	+	2
	3670	+	3
	3671	+	4
	3672	+	5
	3673	+	6
	3674	+	7
	3675	+	8
	3676	+	9
	3677	+	10
	3678	+	11
	3679	+	12
	3680	+	13
	3681	+	14
	3682	+	15
	3683	+	16
	3684	+	17
	3685	+	18
	3686	+	19
	3687	+	20
	3688	+	21
	3689	+	22
	3690	+	23
	3691	+	24
	3692	+
	3693	+	require an individual proceeding for the denial of a new appli cation
	3694	+	for registration.
	3695	+	D. The Director may authorize the Deputy Director or the
	3696	+	General Counsel of the Oklahoma State Bureau of Narcotics and
	3697	+	Dangerous Drugs Control to initiate any individual proceed ings under
	3698	+	this title. Nothing in this section shall be construed so as to
	3699	+	delegate the authority of the Director to issue a final agency order
	3700	+	adverse to a party.
	3701	+	E. All proceedings shall be conducted in accord ance with the
	3702	+	Administrative Procedures Act and the rules and regulations of the
	3703	+	Oklahoma State Bureau of Narcotics and Dangerous Drugs Control
	3704	+	without regard to any criminal prosecution o r other proceeding.
	3705	+	Proceedings to refuse renewal, revoke, or suspend a registration
	3706	+	shall not abate the exist ing registration which shall remain in
	3707	+	effect pending the outcome of those administrative proceedings.
	3708	+	This abatement shall not apply when the D irector finds there is an
	3709	+	imminent danger to the public hea lth or safety requir ing an
	3710	+	immediate suspension.
	3711	+	The Director may delegate to an administrative hearing o fficer
	3712	+	the authority to conduct hearings and recommend action for final
	3713	+	agency orders in acc ordance with the rules and regulations of the
	3714	+	Oklahoma State Bureau of Narcotic s and Dangerous Drugs Control.
	3715	+	F. The Director may issue an order immediately suspen ding a
	3716	+	registration, without notice or a hearing, when he or she finds
	3717	+
	3718	+	ENGR. S. B. NO. 475 Page 33 1
	3719	+	2
	3720	+	3
	3721	+	4
	3722	+	5
	3723	+	6
	3724	+	7
	3725	+	8
	3726	+	9
	3727	+	10
	3728	+	11
	3729	+	12
	3730	+	13
	3731	+	14
	3732	+	15
	3733	+	16
	3734	+	17
	3735	+	18
	3736	+	19
	3737	+	20
	3738	+	21
	3739	+	22
	3740	+	23
	3741	+	24
	3742	+
	3743	+	there is imminent dan ger to the public health or safety which
	3744	+	warrants this action. The suspension shall continue in effect until
	3745	+	the conclusion of any administrative proceedings, incl uding judicial
	3746	+	review thereof, unless sooner withdrawn by the Director or dissolved
	3747	+	by a court of competent jurisdiction. The order shall state the
	3748	+	existence of an emerge ncy requiring action be taken that the
	3749	+	Director deems necessary to meet the emergency . Such action may
	3750	+	include, but is not limited to, ordering the registrant to
	3751	+	immediately cease and desist operations. The order shall be
	3752	+	effective immediately upon issua nce. Any person to whom the order
	3753	+	is directed shall comply immediately with the prov isions of the
	3754	+	order. The Director may assess a penalty not to exceed Ten Thousand
	3755	+	Dollars ($10,000.00) per day of noncompliance with the order. In
	3756	+	assessing such a penal ty, the Director shall consider the
	3757	+	seriousness of the violation and any efforts to c omply with
	3758	+	applicable requirements. Upon application to the Director, the
	3759	+	registrant shall be offered a hearing within thirty (30) days of the
	3760	+	issuance of the order.
	3761	+	G. In lieu of or in addition to any other remedies available to
	3762	+	the Director, if a findi ng is made that a registrant has committed
	3763	+	any act in violation of federal law relating to a ny controlled
	3764	+	substance, any provision of the Uniform Contr olled Dangerous
	3765	+	Substances Act or any rules of the Oklahoma State Bureau of
	3766	+	Narcotics and Dangerous Drugs Control, the Director is hereby
	3767	+
	3768	+	ENGR. S. B. NO. 475 Page 34 1
	3769	+	2
	3770	+	3
	3771	+	4
	3772	+	5
	3773	+	6
	3774	+	7
	3775	+	8
	3776	+	9
	3777	+	10
	3778	+	11
	3779	+	12
	3780	+	13
	3781	+	14
	3782	+	15
	3783	+	16
	3784	+	17
	3785	+	18
	3786	+	19
	3787	+	20
	3788	+	21
	3789	+	22
	3790	+	23
	3791	+	24
	3792	+
	3793	+	authorized to assess an administrative penalty not to excee d Five
	3794	+	Thousand Dollars ($5,000.00) per day for each such a ct. The
	3795	+	provisions of this subsection shall not apply to violations of
	3796	+	subsection G of Section 2 -309D of this title. Nothing in this
	3797	+	section shall be construed so as to permit the Director of the State
	3798	+	Bureau of Narcotics and Dangerous Drugs Control to a ssess
	3799	+	administrative fines for violations of the provisions of subsection
	3800	+	G of Section 2-309D of this title.
	3801	+	If a judge of competent jurisdiction finds probable cause that a
	3802	+	registrant has possesse d, transferred, sold, or offered for sale any
	3803	+	controlled dangerous in violation of this act, all controlled
	3804	+	dangerous substances in Schedule I of Section 2 -204 of this title
	3805	+	and all controlled dangerous substances in Schedules II, III, IV,
	3806	+	and V that are not in properly labeled containers in accordance with
	3807	+	this act then in the posse ssion of the registrant shall be deemed
	3808	+	contraband and shall be seized and summarily forfeited pursuant to
	3809	+	Section 2-505 of this title. Samples shall be retained of all
	3810	+	controlled dangerous substances seized in accordance with Section 2-
	3811	+	508 of this title as required. The Director is authorized to assess
	3812	+	an eradication or destruction fine not to exceed Fifty Thousand
	3813	+	Dollars ($50,000.00) against the registrant.
	3814	+	H. Upon an annulment, revocation, or denial of a registration
	3815	+	the Director may prohibit the reg istrant or applicant from
	3816	+	reapplying for registration for a period up to five years f ollowing
	3817	+
	3818	+	ENGR. S. B. NO. 475 Page 35 1
	3819	+	2
	3820	+	3
	3821	+	4
	3822	+	5
	3823	+	6
	3824	+	7
	3825	+	8
	3826	+	9
	3827	+	10
	3828	+	11
	3829	+	12
	3830	+	13
	3831	+	14
	3832	+	15
	3833	+	16
	3834	+	17
	3835	+	18
	3836	+	19
	3837	+	20
	3838	+	21
	3839	+	22
	3840	+	23
	3841	+	24
	3842	+
	3843	+	the date of the final order. The length of any prohibition shall
	3844	+	not be used as grounds to contest the validity of the annulment,
	3845	+	revocation, or denial of a registration.
	3846	+	SECTION 13. AMENDATORY 63 O.S. 2021, Section 2 -322, is
	3847	+	amended to read as follows:
	3848	+	Section 2-322. A. No person or business shall possess, se ll,
	3849	+	manufacture, transfer, or otherwise furnish any of the following
	3850	+	precursor substances without first having a permit or license issued
	3851	+	by the Director of t he Oklahoma State Bureau of Narcotics and
	3852	+	Dangerous Drugs Control, except as provided in Section 2 -327 of this
	3853	+	title:
	3854	+	1. D-Lysergic acid;
	3855	+	2. Ergotamine and its salts;
	3856	+	3. Ergonovine and its salts;
	3857	+	4. Methylamine;
	3858	+	5. Ethylamine;
	3859	+	6. Phenyl-2-Propanone;
	3860	+	7. Phenylacetic acid and its salts;
	3861	+	8. Ephedrine, its salts, optical isomers and salts of optica l
	3862	+	isomers;
	3863	+	9. Norpseudoephedrine, its salts, optical isomers, and salts of
	3864	+	optical isomers;
	3865	+	10. Phenylpropanolamine, its salts, optical isomers and salts
	3866	+	of optical isomers;
	3867	+
	3868	+	ENGR. S. B. NO. 475 Page 36 1
	3869	+	2
	3870	+	3
	3871	+	4
	3872	+	5
	3873	+	6
	3874	+	7
	3875	+	8
	3876	+	9
	3877	+	10
	3878	+	11
	3879	+	12
	3880	+	13
	3881	+	14
	3882	+	15
	3883	+	16
	3884	+	17
	3885	+	18
	3886	+	19
	3887	+	20
	3888	+	21
	3889	+	22
	3890	+	23
	3891	+	24
	3892	+
	3893	+	11. Benzyl cyanide;
	3894	+	12. N-methylephedrine, its salts, optical isomers and salt s of
	3895	+	optical isomers;
	3896	+	13. Pseudoephedrine, its salts, optical isomers and salts of
	3897	+	optical isomers;
	3898	+	14. Chloroephedrine, its salts, optical isomers and salt s of
	3899	+	optical isomers;
	3900	+	15. Piperidine and its salts;
	3901	+	16. Pyrrolidine and its salts;
	3902	+	17. Propionic anhydride;
	3903	+	18. Isosafrole;
	3904	+	19. Safrole;
	3905	+	20. Piperonal; and
	3906	+	21. Red Phosphorus.
	3907	+	B. Upon completion of an application for a license pursuant to
	3908	+	Section 2-323 of this title, or a permit pursuant to Section 2 -324
	3909	+	of this title, the Director of the Oklah oma State Bureau of
	3910	+	Narcotics and Dangerous Drugs Control shall either grant or deny
	3911	+	such license or permit. A denial of an application for a permit or
	3912	+	license shall be handled as provided by Section 2 -325 of this title.
	3913	+	SECTION 14. AMENDATORY 63 O.S. 2021, Section 2 -325, is
	3914	+	amended to read as follows:
	3915	+	Section 2-325. A. A license or permit, obtained pursuant to
	3916	+	Sections 5 Section 2-323 or 6 2-324 of this act title, shall be
	3917	+
	3918	+	ENGR. S. B. NO. 475 Page 37 1
	3919	+	2
	3920	+	3
	3921	+	4
	3922	+	5
	3923	+	6
	3924	+	7
	3925	+	8
	3926	+	9
	3927	+	10
	3928	+	11
	3929	+	12
	3930	+	13
	3931	+	14
	3932	+	15
	3933	+	16
	3934	+	17
	3935	+	18
	3936	+	19
	3937	+	20
	3938	+	21
	3939	+	22
	3940	+	23
	3941	+	24
	3942	+
	3943	+	denied annulled, suspended, or revoked by the Director u pon finding
	3944	+	that the licensee or pe rmit holder has:
	3945	+	1. Materially falsified any application filed pursuant to this
	3946	+	act Section 2-321 et seq. of this title or required by this act the
	3947	+	Precursor Substances Act ;
	3948	+	2. Been convicted of a misdemeanor relating t o any precursor
	3949	+	substance defined in Section 4 2-322 of this act title or any felony
	3950	+	under the laws of this stat e or the United States; or
	3951	+	3. Failed to maintain ef fective controls against the diversion
	3952	+	of said the precursors to unauthorized persons or ent ities.
	3953	+	B. Before denying annulling, suspending, or revoking a lice nse
	3954	+	or permit, the Director shall cause to be ser ved upon the applicant,
	3955	+	licensee, or permit holder an order to show cause why a license or a
	3956	+	permit should not be denied annulled, suspended, or revoked. The
	3957	+	order to show cause shall contain a s tatement of the basis therefor
	3958	+	and shall call upon the applicant, licensee, or permit holder to
	3959	+	appear before the appropriate person or agency at the time and place
	3960	+	within thirty (30) sixty (60) days after the date of service of the
	3961	+	order. The proceedings shall be c onducted in accordance with the
	3962	+	Administrative Procedures Act without regard to any criminal
	3963	+	prosecution or other proceeding. Nothing in this section shall be
	3964	+	construed so as to require an individual proceeding for the denial
	3965	+	of a new license or permit.
	3966	+
	3967	+	ENGR. S. B. NO. 475 Page 38 1
	3968	+	2
	3969	+	3
	3970	+	4
	3971	+	5
	3972	+	6
	3973	+	7
	3974	+	8
	3975	+	9
	3976	+	10
	3977	+	11
	3978	+	12
	3979	+	13
	3980	+	14
	3981	+	15
	3982	+	16
	3983	+	17
	3984	+	18
	3985	+	19
	3986	+	20
	3987	+	21
	3988	+	22
	3989	+	23
	3990	+	24
	3991	+
	3992	+	C. The Director shall suspend, without an order t o show cause,
	3993	+	any license or permit simultaneously with the institution of
	3994	+	proceedings described in subsection B of this section if he finds
	3995	+	there is imminent danger to the public health or safety which
	3996	+	warrants this action. The suspension shall continue in effect until
	3997	+	the conclusion of the proceedings, including judicial review
	3998	+	thereof, unless withdrawn by the Director or dissolved by a cou rt of
	3999	+	competent jurisdiction.
	4000	+	SECTION 15. AMENDATORY 63 O.S. 2021, Section 2-406, is
	4001	+	amended to read as follows:
	4002	+	Section 2-406. A. It shall be unlawful for any registrant
	4003	+	knowingly or intentionally:
	4004	+	1. To distribute, other than by dispensing or as otherwise
	4005	+	authorized by this act Section 2-101 et seq. of this title, a
	4006	+	controlled dangerous substance classified in Schedules I or II, in
	4007	+	the course of his legitimate business, except pursua nt to an order
	4008	+	form as required by Section 2 -308 of this title;
	4009	+	2. To use in the course of the manu facture or distribution of a
	4010	+	controlled dangerous substance a registration number which is
	4011	+	fictitious, revoked, suspended or issued to another person;
	4012	+	3. To acquire or obtain possession of a controlle d dangerous
	4013	+	substance by misrepresentation, fraud, forg ery, deception or
	4014	+	subterfuge;
	4015	+
	4016	+	ENGR. S. B. NO. 475 Page 39 1
	4017	+	2
	4018	+	3
	4019	+	4
	4020	+	5
	4021	+	6
	4022	+	7
	4023	+	8
	4024	+	9
	4025	+	10
	4026	+	11
	4027	+	12
	4028	+	13
	4029	+	14
	4030	+	15
	4031	+	16
	4032	+	17
	4033	+	18
	4034	+	19
	4035	+	20
	4036	+	21
	4037	+	22
	4038	+	23
	4039	+	24
	4040	+
	4041	+	4. To furnish false or fraudulent material information in, o r
	4042	+	omit any material information from, any application, report, or
	4043	+	other document required to be kept or filed under this act, or any
	4044	+	record required to be kept by this act Section 2-101 et seq. of this
	4045	+	title; and
	4046	+	5. To make, distribute, or possess any punch, die, plate,
	4047	+	stone, or other thing designed to print, imprint, or reproduce the
	4048	+	trademark, trade name, or other identifying mark, imprint, or device
	4049	+	of another or any likeness of any of the foregoing upon any drug or
	4050	+	container or labeling thereof so as to render such dru g a
	4051	+	counterfeit controlled dangerous substance; and
	4052	+	6. To purchase, attempt, endeavor and conspire or endeavor or
	4053	+	conspire to obtain and purchase o r obtain or purchase, any license
	4054	+	or registration required to distribute , possess, prescribe, or
	4055	+	manufacture any controlled dangerous substance, on behalf of or at
	4056	+	the request or demand of any person, through the use of a straw
	4057	+	person or party as defined in Section 2-101 of this title.
	4058	+	B. Any person who violates this section is guilty of a felony
	4059	+	punishable by imprisonment for not more than twenty (20) years or a
	4060	+	fine of not more than Two Hu ndred Fifty Thousand Dollars
	4061	+	($250,000.00), or both.
	4062	+	C. Any person convicted of a second or subsequent violation of
	4063	+	this section is punishable by a term of imprisonment twic e that
	4064	+	otherwise authorized and by twice the fine otherwise authorized.
	4065	+
	4066	+	ENGR. S. B. NO. 475 Page 40 1
	4067	+	2
	4068	+	3
	4069	+	4
	4070	+	5
	4071	+	6
	4072	+	7
	4073	+	8
	4074	+	9
	4075	+	10
	4076	+	11
	4077	+	12
	4078	+	13
	4079	+	14
	4080	+	15
	4081	+	16
	4082	+	17
	4083	+	18
	4084	+	19
	4085	+	20
	4086	+	21
	4087	+	22
	4088	+	23
	4089	+	24
	4090	+
	4091	+	Convictions for second or subsequent violations of this section
	4092	+	shall not be subject to statutory provisions for suspended
	4093	+	sentences, deferred sentences, or probation.
1214	4094		D. Any person convicted of any offense described in this
1215	4095		section shall, in addition to any fine imposed, pay a special
1216	4096		assessment trauma-care fee of One Hundred Dol lars ($100.00) to be
1217	4097		deposited into the Trauma Care Assistance Revolving Fund cr eated in
1218	4098		Section 1-2522 1-2530.9 of this title.
1219		-
1220		-	SECTION 8. It being immediately necessary for the pr eservation
	4099	+	SECTION 16. It being immediately necessary for the pr eservation
1221	4100		of the public peace, health or safety, an emergency is hereby
1222	4101		declared to exist, by reason whereof this act shall take ef fect and
1223	4102		be in full force from and after its passage and approval.
1224		-
1225		-
1226		-	ENR. S. B. NO. 475 Page 29
1227		-	Passed the Senate the 19th day of May, 2023.
	4103	+	Passed the Senate the 21st day of March, 2023.
1228	4104
1229	4105
1230	4106
1231	4107		Presiding Officer of the Senate
1232	4108
1233	4109
1234		-	Passed the House of Representatives the 24th day of April, 2023.
	4110	+	Passed the House of Representatives the ____ day of __________,
	4111	+	2023.
1235	4112
1236	4113
1237	4114
1238	4115		Presiding Officer of the House
1239	4116		of Representatives
1240	4117
1241		-	OFFICE OF THE GOVERNOR
1242		-	Received by the Office of the Governor this _______ _____________
1243		-	day of ___________________, 20_______, at _______ o'clock _______ M.
1244		-	By: _______________________________ __
1245		-	Approved by the Governor of the State of Oklahoma this _____ ____
1246		-	day of _________________ __, 20_______, at ____ ___ o'clock _______ M.
1247		-
1248		-	_____________________________ ____
1249		-	Governor of the State of Oklahoma
1250		-
1251		-
1252		-	OFFICE OF THE SECRETARY OF STATE
1253		-	Received by the Office of the Secretary of State this _______ ___
1254		-	day of __________________, 20 _______, at _______ o'clock ____ ___ M.
1255		-	By: _______________________________ __
	4118	+